No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1gztD_, 1.0000, 0.00, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) TOGETHER WITH FUCOSE
2, d2vucD_, 0.9997, 0.06, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
3, d2bp6C_, 0.9996, 0.07, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH A-L-GALACTOPYRANOSIDE
4, d2jdnD_, 0.9995, 0.08, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-MANNOPYRANOSIDE
5, d2jdkD_, 0.9995, 0.08, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
6, d1uzvD_, 0.9995, 0.08, 1.000, 114, 114, HIGH AFFINITY FUCOSE BINDING OF PSEUDOMONAS AERUGINOSA LECTIN II: 1.0 A CRYSTAL STRUCTURE OF THE COMPLEX
7, d4ce8A_, 0.9994, 0.09, 1.000, 114, 114, PERDEUTERATED PSEUDOMONAS AERUGINOSA LECTIN II COMPLEX WITH HYDROGENATED L-FUCOSE AND CALCIUM
8, d2jdhD_, 0.9994, 0.09, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
9, p5nf0D_, 0.9991, 0.12, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
10, d2jdmD_, 0.9991, 0.12, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
11, d3zdvA_, 0.9990, 0.12, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(246-TRIMETHYLPHENYLSULFONYLAMIDO)- 6-DEOXY-ALPHA-D-MANNOPYRANOSIDE
12, d2vudD_, 0.9987, 0.14, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
13, d1w8hA_, 0.9987, 0.14, 1.000, 114, 114, STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LEWISA TRISACCHARIDE
14, p5nesA_, 0.9986, 0.14, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
15, p5nf0B_, 0.9985, 0.15, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
16, p5nesB_, 0.9985, 0.15, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
17, p5nesD_, 0.9984, 0.16, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
18, p5i8xC_, 0.9984, 0.16, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
19, d3zdvC_, 0.9984, 0.16, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(246-TRIMETHYLPHENYLSULFONYLAMIDO)- 6-DEOXY-ALPHA-D-MANNOPYRANOSIDE
20, p5i8xB_, 0.9983, 0.16, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
21, p5i8mA_, 0.9983, 0.16, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
22, d1w8hD_, 0.9983, 0.16, 1.000, 114, 114, STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LEWISA TRISACCHARIDE
23, p5i8xA_, 0.9982, 0.17, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
24, p5i8mC_, 0.9982, 0.16, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
25, p5neyC_, 0.9981, 0.17, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
26, p5d2aB_, 0.9981, 0.17, 1.000, 114, 114, BIFUNCTIONAL DENDRIMERS
27, d2jdnC_, 0.9981, 0.17, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-MANNOPYRANOSIDE
28, d2jdkC_, 0.9981, 0.17, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
29, d2bojC_, 0.9981, 0.17, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH METHYL-B-D-ARABINOPYRANOSIDE
30, d1uzvC_, 0.9981, 0.17, 1.000, 114, 114, HIGH AFFINITY FUCOSE BINDING OF PSEUDOMONAS AERUGINOSA LECTIN II: 1.0 A CRYSTAL STRUCTURE OF THE COMPLEX
31, d1ovpA_, 0.9981, 0.17, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FRUCTOSE
32, d1ourA_, 0.9981, 0.17, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH MANNOSE
33, p5i8xD_, 0.9980, 0.17, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
34, p5i8mD_, 0.9980, 0.18, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
35, d3zdvD_, 0.9980, 0.17, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(246-TRIMETHYLPHENYLSULFONYLAMIDO)- 6-DEOXY-ALPHA-D-MANNOPYRANOSIDE
36, d5a3oC_, 0.9979, 0.18, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(CINNAMIDO)-6-DEOXY- ALPHA-D-MANNOPYRANOSIDE AT 1.6 ANSGTROM
37, d2jdpD_, 0.9979, 0.18, 0.991, 114, 114, MUTANT (S23A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
38, d2bp6B_, 0.9979, 0.18, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH A-L-GALACTOPYRANOSIDE
39, d1oxcC_, 0.9979, 0.18, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FUCOSE
40, p5neyD_, 0.9978, 0.18, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
41, d5mazB_, 0.9978, 0.18, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-THIOPHENESULFONAMIDE-25-DIMETHYL-N-METHYL-BETA-L- FUCOPYRANOSIDE
42, p5i8mB_, 0.9978, 0.18, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
43, p5d2aA_, 0.9978, 0.18, 1.000, 114, 114, BIFUNCTIONAL DENDRIMERS
44, d3zdvB_, 0.9978, 0.18, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(246-TRIMETHYLPHENYLSULFONYLAMIDO)- 6-DEOXY-ALPHA-D-MANNOPYRANOSIDE
45, d2bp6D_, 0.9978, 0.18, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH A-L-GALACTOPYRANOSIDE
46, d1w8fA_, 0.9978, 0.19, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LACTO-N-NEO-FUCOPENTAOSE V(LNPFV)
47, d1gztC_, 0.9978, 0.19, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) TOGETHER WITH FUCOSE
48, d5a6zA_, 0.9977, 0.19, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A
49, d2vucC_, 0.9977, 0.19, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
50, d2jdhC_, 0.9977, 0.19, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
51, d5a3oA_, 0.9976, 0.19, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(CINNAMIDO)-6-DEOXY- ALPHA-D-MANNOPYRANOSIDE AT 1.6 ANSGTROM
52, d2jduC_, 0.9976, 0.19, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
53, d2bojD_, 0.9976, 0.19, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH METHYL-B-D-ARABINOPYRANOSIDE
54, d1oxcD_, 0.9976, 0.19, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FUCOSE
55, d5a6yA_, 0.9975, 0.20, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA13MANNOSIDE
56, d2jdpB_, 0.9975, 0.20, 0.991, 114, 114, MUTANT (S23A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
57, d1gztB_, 0.9975, 0.19, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) TOGETHER WITH FUCOSE
58, p5ngqB_, 0.9974, 0.20, 1.000, 114, 114, BICYCLIC ANTIMICROBIAL PEPTIDES
59, p5ngqA_, 0.9974, 0.20, 1.000, 114, 114, BICYCLIC ANTIMICROBIAL PEPTIDES
60, p5nesC_, 0.9974, 0.20, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
61, d2jdkB_, 0.9974, 0.20, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
62, d2bojB_, 0.9974, 0.20, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH METHYL-B-D-ARABINOPYRANOSIDE
63, d5mazD_, 0.9973, 0.20, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-THIOPHENESULFONAMIDE-25-DIMETHYL-N-METHYL-BETA-L- FUCOPYRANOSIDE
64, d5a6yB_, 0.9973, 0.21, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA13MANNOSIDE
65, d2jdmC_, 0.9973, 0.20, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
66, d2jdmB_, 0.9973, 0.20, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
67, d1uzvB_, 0.9973, 0.20, 1.000, 114, 114, HIGH AFFINITY FUCOSE BINDING OF PSEUDOMONAS AERUGINOSA LECTIN II: 1.0 A CRYSTAL STRUCTURE OF THE COMPLEX
68, p5nf0A_, 0.9972, 0.21, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
69, d5a6qB_, 0.9972, 0.21, 0.868, 114, 114, NATIVE STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14
70, d1w8fC_, 0.9972, 0.21, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LACTO-N-NEO-FUCOPENTAOSE V(LNPFV)
71, p5ngqC_, 0.9971, 0.21, 1.000, 114, 114, BICYCLIC ANTIMICROBIAL PEPTIDES
72, d5a6qA_, 0.9971, 0.21, 0.868, 114, 114, NATIVE STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14
73, d2jdhB_, 0.9971, 0.21, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
74, d2bojA_, 0.9971, 0.21, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH METHYL-B-D-ARABINOPYRANOSIDE
75, d1w8hC_, 0.9971, 0.21, 1.000, 114, 114, STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LEWISA TRISACCHARIDE
76, d1w8fD_, 0.9971, 0.21, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LACTO-N-NEO-FUCOPENTAOSE V(LNPFV)
77, d1w8fB_, 0.9971, 0.21, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LACTO-N-NEO-FUCOPENTAOSE V(LNPFV)
78, d1ouxC_, 0.9971, 0.21, 1.000, 114, 114, LECB (PA-LII) SUGAR-FREE
79, d5a6yD_, 0.9970, 0.21, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA13MANNOSIDE
80, d5a6qD_, 0.9970, 0.21, 0.868, 114, 114, NATIVE STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14
81, d2vudC_, 0.9970, 0.22, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
82, d2vucB_, 0.9970, 0.21, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
83, d2jdyC_, 0.9970, 0.21, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-B-D-MANNOYRANOSIDE
84, d5a70B_, 0.9969, 0.22, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE
85, d1oxcB_, 0.9969, 0.22, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FUCOSE
86, p5ngqD_, 0.9968, 0.22, 1.000, 114, 114, BICYCLIC ANTIMICROBIAL PEPTIDES
87, d5mb1B_, 0.9968, 0.22, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 246-TRIMETHYLPHENYLSULFONAMIDE-N-METHYL-L- FUCOPYRANOSIDE
88, d5mb1A_, 0.9968, 0.22, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 246-TRIMETHYLPHENYLSULFONAMIDE-N-METHYL-L- FUCOPYRANOSIDE
89, p5neyA_, 0.9967, 0.22, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
90, d5a6zC_, 0.9967, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A
91, d5a6yC_, 0.9967, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA13MANNOSIDE
92, d5a6xB_, 0.9967, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
93, d2jdnB_, 0.9967, 0.22, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-MANNOPYRANOSIDE
94, d1w8hB_, 0.9967, 0.23, 1.000, 114, 114, STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LEWISA TRISACCHARIDE
95, d1ovsC_, 0.9967, 0.23, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH CORE TRIMANNOSIDE
96, p5nf0C_, 0.9966, 0.23, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
97, d5mazC_, 0.9966, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-THIOPHENESULFONAMIDE-25-DIMETHYL-N-METHYL-BETA-L- FUCOPYRANOSIDE
98, d5mayB_, 0.9966, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-THIOPHENESULFONAMIDE-N-(BETA-L-FUCOPYRANOSYL METHYL)
99, d2jdyB_, 0.9966, 0.23, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-B-D-MANNOYRANOSIDE
100, d2jdyA_, 0.9966, 0.23, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-B-D-MANNOYRANOSIDE
101, d5a6zB_, 0.9965, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A
102, d5a6qC_, 0.9965, 0.23, 0.868, 114, 114, NATIVE STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14
103, d3dcqD_, 0.9965, 0.23, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH THE SYNTHETIC LIGAND 2G0
104, d5mb1D_, 0.9964, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 246-TRIMETHYLPHENYLSULFONAMIDE-N-METHYL-L- FUCOPYRANOSIDE
105, d5a70C_, 0.9964, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE
106, d4ut5A_, 0.9964, 0.24, 0.904, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE
107, d2vudB_, 0.9964, 0.24, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
108, d2jdpC_, 0.9964, 0.24, 0.991, 114, 114, MUTANT (S23A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
109, d1ovsB_, 0.9964, 0.24, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH CORE TRIMANNOSIDE
110, d1ouxB_, 0.9964, 0.23, 1.000, 114, 114, LECB (PA-LII) SUGAR-FREE
111, d5mayD_, 0.9963, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-THIOPHENESULFONAMIDE-N-(BETA-L-FUCOPYRANOSYL METHYL)
112, d5a6xD_, 0.9963, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
113, d5a6xC_, 0.9962, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
114, d4ut5D_, 0.9962, 0.24, 0.904, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE
115, d3dcqB_, 0.9962, 0.24, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH THE SYNTHETIC LIGAND 2G0
116, d5a6xA_, 0.9961, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
117, d3dcqC_, 0.9961, 0.25, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH THE SYNTHETIC LIGAND 2G0
118, d2jduA_, 0.9961, 0.25, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
119, d2jdpA_, 0.9961, 0.25, 0.991, 114, 114, MUTANT (S23A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
120, d1ouxD_, 0.9961, 0.24, 1.000, 114, 114, LECB (PA-LII) SUGAR-FREE
121, d5a6zD_, 0.9960, 0.25, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A
122, d1ovsD_, 0.9959, 0.25, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH CORE TRIMANNOSIDE
123, d5a70D_, 0.9958, 0.26, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE
124, d5a3oB_, 0.9957, 0.26, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(CINNAMIDO)-6-DEOXY- ALPHA-D-MANNOPYRANOSIDE AT 1.6 ANSGTROM
125, d4ut5B_, 0.9957, 0.26, 0.904, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE
126, d2jdyD_, 0.9957, 0.26, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-B-D-MANNOYRANOSIDE
127, d1gztA_, 0.9956, 0.28, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) TOGETHER WITH FUCOSE
128, d4ut5C_, 0.9955, 0.28, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE
129, d1uzvA_, 0.9955, 0.26, 0.904, 114, 114, HIGH AFFINITY FUCOSE BINDING OF PSEUDOMONAS AERUGINOSA LECTIN II: 1.0 A CRYSTAL STRUCTURE OF THE COMPLEX
130, d2jduB_, 0.9954, 0.29, 1.000, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
131, d2jdkA_, 0.9954, 0.27, 0.991, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
132, p5neyB_, 0.9953, 0.29, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
133, d5a3oD_, 0.9953, 0.27, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(CINNAMIDO)-6-DEOXY- ALPHA-D-MANNOPYRANOSIDE AT 1.6 ANSGTROM
134, d2jdhA_, 0.9953, 0.28, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
135, d2bp6A_, 0.9952, 0.29, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH A-L-GALACTOPYRANOSIDE
136, d2vucA_, 0.9949, 0.29, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
137, d2jdnA_, 0.9949, 0.31, 1.000, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-MANNOPYRANOSIDE
138, d1ovsA_, 0.9949, 0.31, 0.991, 114, 114, LECB (PA-LII) IN COMPLEX WITH CORE TRIMANNOSIDE
139, d4ce8D_, 0.9947, 0.28, 1.000, 114, 114, PERDEUTERATED PSEUDOMONAS AERUGINOSA LECTIN II COMPLEX WITH HYDROGENATED L-FUCOSE AND CALCIUM
140, d2jdmA_, 0.9947, 0.31, 1.000, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
141, p5hchA_, 0.9946, 0.31, 0.991, 114, 114, X-RAY STRUCTURE OF A LECTIN-BOUND DNA DUPLEX CONTAINING AN UNNATURAL PHENANTHRENYL PAIR
142, d2jduD_, 0.9944, 0.29, 1.000, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
143, d1ousB_, 0.9943, 0.31, 0.991, 114, 114, LECB (PA-LII) CALCIUM-FREE
144, d1oxcA_, 0.9942, 0.30, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FUCOSE
145, d3dcqA_, 0.9938, 0.30, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH THE SYNTHETIC LIGAND 2G0
146, d4ce8B_, 0.9937, 0.32, 1.000, 114, 114, PERDEUTERATED PSEUDOMONAS AERUGINOSA LECTIN II COMPLEX WITH HYDROGENATED L-FUCOSE AND CALCIUM
147, d2vudA_, 0.9936, 0.33, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
148, d1ouxA_, 0.9930, 0.34, 1.000, 114, 114, LECB (PA-LII) SUGAR-FREE
149, d1ousC_, 0.9930, 0.33, 1.000, 114, 114, LECB (PA-LII) CALCIUM-FREE
150, d5mazA_, 0.9884, 0.34, 1.000, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-THIOPHENESULFONAMIDE-25-DIMETHYL-N-METHYL-BETA-L- FUCOPYRANOSIDE
151, d5mayC_, 0.9883, 0.21, 0.867, 113, 113, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-THIOPHENESULFONAMIDE-N-(BETA-L-FUCOPYRANOSYL METHYL)
152, d5mayA_, 0.9879, 0.21, 0.867, 113, 113, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-THIOPHENESULFONAMIDE-N-(BETA-L-FUCOPYRANOSYL METHYL)
153, d4ce8C_, 0.9879, 0.23, 0.867, 113, 113, PERDEUTERATED PSEUDOMONAS AERUGINOSA LECTIN II COMPLEX WITH HYDROGENATED L-FUCOSE AND CALCIUM
154, d5a70A_, 0.9871, 0.23, 1.000, 113, 113, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE
155, d5mb1C_, 0.9796, 0.25, 0.867, 113, 113, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 246-TRIMETHYLPHENYLSULFONAMIDE-N-METHYL-L- FUCOPYRANOSIDE
156, d1ousA_, 0.9792, 0.80, 0.868, 114, 114, LECB (PA-LII) CALCIUM-FREE
157, d1uqxA_, 0.9773, 0.45, 1.000, 113, 113, RALSTONIA SOLANACEARUM LECTIN (RS-IIL) IN COMPLEX WITH ALPHA-METHYLMANNOSIDE
158, d1vyyA_, 0.9770, 0.48, 0.699, 113, 113,  
159, d2chhA_, 0.9767, 0.48, 0.699, 113, 113, RALSTONIA SOLANACEARUM HIGH-AFFINITY MANNOSE-BINDING LECTIN
160, d2boiB_, 0.9696, 0.49, 0.699, 113, 113, 1.1A STRUCTURE OF CHROMOBACTERIUM VIOLACEUM LECTIN CV2L IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
161, d2bv4A_, 0.9686, 0.64, 0.611, 113, 113, 1.0A STRUCTURE OF CHROMOBACTERIUM VIOLACEUM LECTIN IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE
162, d2bv4B_, 0.9683, 0.65, 0.611, 113, 113, 1.0A STRUCTURE OF CHROMOBACTERIUM VIOLACEUM LECTIN IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE
163, d2boiA_, 0.9683, 0.66, 0.611, 113, 113, 1.1A STRUCTURE OF CHROMOBACTERIUM VIOLACEUM LECTIN CV2L IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
164, d1ousD_, 0.9516, 0.66, 0.611, 113, 113, LECB (PA-LII) CALCIUM-FREE
165, d2xr4A1, 0.9124, 0.27, 1.000, 109, 109, C-TERMINAL DOMAIN OF BC2L-C LECTIN FROM BURKHOLDERIA CENOCEPACIA
166, d2xr4B1, 0.9035, 1.34, 0.464, 115, 112, C-TERMINAL DOMAIN OF BC2L-C LECTIN FROM BURKHOLDERIA CENOCEPACIA
167, d2wraA_, 0.8968, 1.34, 0.464, 115, 112, BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA COMPLEXED WITH AMAN1(AMAN1-6)-3MAN TRISACCHARIDE
168, d2vnvE_, 0.8938, 1.67, 0.460, 115, 113, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
169, d2vnvC_, 0.8937, 1.56, 0.378, 122, 111, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
170, d2vnvD_, 0.8921, 1.58, 0.378, 128, 111, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
171, d2wr9D_, 0.8916, 1.59, 0.378, 127, 111, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE
172, d2vnvB_, 0.8915, 1.59, 0.378, 128, 111, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
173, d2wr9C_, 0.8896, 1.59, 0.378, 124, 111, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE
174, d4aocB_, 0.8881, 1.58, 0.378, 128, 111, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
175, d2wr9A_, 0.8874, 1.58, 0.378, 128, 111, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE
176, d2wr9B_, 0.8858, 1.56, 0.378, 121, 111, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE
177, d4aocE_, 0.8824, 1.49, 0.382, 120, 110, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
178, d4aocC_, 0.8824, 1.42, 0.385, 119, 109, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
179, d2vnvA_, 0.8824, 1.62, 0.378, 123, 111, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
180, d4aocD_, 0.8765, 1.75, 0.378, 121, 111, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
181, d4aocA_, 0.8691, 1.64, 0.373, 120, 110, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
182, p3q13A_, 0.6169, 1.67, 0.382, 120, 110, THE STRUCTURE OF THE CA2+-BINDING GLYCOSYLATED F-SPONDIN DOMAIN OF F- SPONDIN A C2-DOMAIN VARIANT FROM EXTRACELLULAR MATRIX
183, p3d34B_, 0.6169, 1.46, 0.389, 118, 108, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
184, p3d34A_, 0.6097, 1.44, 0.383, 117, 107, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
185, p4rj9A_, 0.5960, 3.53, 0.078, 235, 103, STRUCTURE OF A PLANT SPECIFIC C2 DOMAIN PROTEIN OSGAP1 FROM RICE
186, p3n0aA2, 0.5958, 3.53, 0.078, 235, 103, CRYSTAL STRUCTURE OF AUXILIN (40-400)
187, d5bzzD2, 0.5955, 3.54, 0.098, 215, 102, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
188, d1gmiA_, 0.5936, 3.54, 0.098, 215, 102, STRUCTURE OF THE C2 DOMAIN FROM NOVEL PROTEIN KINASE C EPSILON
189, p4icwA_, 0.5932, 3.46, 0.121, 211, 99, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
190, d5bugB2, 0.5927, 3.44, 0.109, 161, 101, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
191, d5bzzC2, 0.5920, 3.40, 0.101, 149, 99, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
192, d5bzzB2, 0.5920, 3.40, 0.101, 149, 99, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
193, d2fk9A1, 0.5918, 3.66, 0.088, 140, 102, HUMAN PROTEIN KINASE C ETA
194, p6ewpA_, 0.5915, 3.63, 0.157, 135, 102, MUS MUSCULUS CEP120 THIRD C2 DOMAIN (C2C) 
195, d5bzzA2, 0.5914, 3.56, 0.069, 130, 102, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
196, d5bugA2, 0.5911, 3.74, 0.087, 140, 103, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
197, p5a51A_, 0.5900, 3.84, 0.087, 140, 103, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND PHOPHATIDYL SERINE
198, p6ewpC_, 0.5888, 3.84, 0.097, 140, 103, MUS MUSCULUS CEP120 THIRD C2 DOMAIN (C2C) 
199, p4p42B3, 0.5884, 3.37, 0.110, 139, 100, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
200, d5bzxB2, 0.5882, 3.37, 0.110, 139, 100, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
201, p4v29A_, 0.5881, 3.65, 0.019, 166, 105, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS
202, d5bugC2, 0.5876, 3.67, 0.088, 140, 102, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
203, p6flkB_, 0.5875, 3.71, 0.088, 140, 102, CRYSTAL STRUCTURE OF CEP120 C2C DOMAIN
204, p6ewlA_, 0.5875, 3.71, 0.088, 140, 102, DANIO RERIO CEP120 FIRST C2 DOMAIN (C2A) 
205, p5a4xA_, 0.5870, 3.42, 0.109, 165, 101, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND ZN
206, d5bugD2, 0.5868, 3.54, 0.038, 167, 104, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
207, p4npjA1, 0.5866, 3.33, 0.070, 146, 100, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
208, p4ihbE_, 0.5866, 3.80, 0.087, 140, 103, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
209, p4ihbA_, 0.5866, 3.38, 0.109, 165, 101, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
210, d5bzxD2, 0.5864, 3.38, 0.109, 165, 101, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
211, d5bzxC2, 0.5861, 3.75, 0.088, 140, 102, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
212, p4p42A3, 0.5858, 3.59, 0.029, 154, 104, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
213, p5a51B_, 0.5854, 3.61, 0.069, 136, 101, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND PHOPHATIDYL SERINE
214, p5a50A_, 0.5847, 3.41, 0.109, 158, 101, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS ZN AND PHOPHO CHOLINE
215, p4qamB_, 0.5838, 3.64, 0.089, 140, 101, CRYSTAL STRUCTURE OF THE RPGR RCC1-LIKE DOMAIN IN COMPLEX WITH THE RPGR-INTERACTING DOMAIN OF RPGRIP1
216, d5bzxA2, 0.5837, 3.48, 0.069, 149, 101, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
217, p6flkA_, 0.5830, 3.48, 0.069, 149, 101, CRYSTAL STRUCTURE OF CEP120 C2C DOMAIN
218, d2vmhA_, 0.5825, 3.40, 0.110, 126, 100, THE STRUCTURE OF CBM51 FROM CLOSTRIDIUM PERFRINGENS GH95
219, d2vmgA1, 0.5822, 3.28, 0.111, 126, 99, THE STRUCTURE OF CBM51 FROM CLOSTRIDIUM PERFRINGENS GH95 IN COMPLEX WITH METHYL-GALACTOSE
220, p4v29B_, 0.5820, 3.89, 0.087, 140, 104, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS
221, p6fljA_, 0.5819, 3.73, 0.088, 140, 102, CRYSTAL STRUCTURE OF CEP120 C2A_K76A MUTANT
222, p4xh3A2, 0.5819, 3.47, 0.059, 140, 101, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
223, p4ihbD_, 0.5818, 3.44, 0.109, 165, 101, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
224, p3l4cA_, 0.5818, 3.41, 0.109, 165, 101, STRUCTURAL BASIS OF MEMBRANE-TARGETING BY DOCK180
225, p4npkA2, 0.5817, 3.55, 0.099, 164, 101, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS CALCIUM BOUND
226, p4icxC_, 0.5816, 3.55, 0.099, 164, 101, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
227, p4ihbB_, 0.5815, 3.75, 0.088, 140, 102, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
228, p3w56A_, 0.5815, 3.52, 0.029, 154, 103, STRUCTURE OF A C2 DOMAIN
229, p5a4xB_, 0.5814, 3.52, 0.029, 154, 103, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND ZN
230, p4ihbF_, 0.5808, 2.76, 0.119, 147, 84, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
231, p5a50B_, 0.5805, 2.76, 0.119, 147, 84, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS ZN AND PHOPHO CHOLINE
232, p4ihbC_, 0.5804, 2.79, 0.119, 145, 84, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
233, p3jzyA_, 0.5799, 3.34, 0.110, 165, 100, CRYSTAL STRUCTURE OF HUMAN INTERSECTIN 2 C2 DOMAIN
234, p5a52A_, 0.5797, 3.63, 0.079, 127, 101, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR1 IN COMPLEX WITH ONE CALCIUM ION
235, p4icxA_, 0.5797, 3.51, 0.051, 136, 99, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
236, p6ewpB_, 0.5795, 3.41, 0.110, 128, 100, MUS MUSCULUS CEP120 THIRD C2 DOMAIN (C2C) 
237, d1wfjA1, 0.5795, 3.41, 0.110, 128, 100, C2 DOMAIN-CONTAINING PROTEIN FROM PUTATIVE ELICITOR- RESPONSIVE GENE
238, d2cjtB_, 0.5794, 3.45, 0.072, 178, 97, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
239, d1cjyA1, 0.5793, 3.33, 0.070, 142, 100, HUMAN CYTOSOLIC PHOSPHOLIPASE A2
240, p4icxB_, 0.5792, 3.63, 0.069, 130, 101, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
241, d2vmiA_, 0.5791, 3.39, 0.110, 126, 100, THE STRUCTURE OF SELENO-METHIONINE LABELLED CBM51 FROM CLOSTRIDIUM PERFRINGENS GH95
242, p4npjB1, 0.5778, 3.25, 0.053, 108, 95, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
243, p4xoiB_, 0.5776, 3.37, 0.110, 163, 100, STRUCTURE OF HSANILLIN BOUND WITH RHOA(Q63L) AT 2.1 ANGSTROMS RESOLUTION
244, d2cjtA1, 0.5776, 3.38, 0.110, 126, 100, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
245, p2yglA1, 0.5775, 3.35, 0.110, 165, 100, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71
246, p2ygmB1, 0.5772, 3.47, 0.110, 127, 100, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN
247, p2yglB1, 0.5766, 3.47, 0.071, 124, 99, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71
248, p4y1sA_, 0.5765, 3.47, 0.071, 124, 99, STRUCTURAL BASIS FOR CA2+-MEDIATED INTERACTION OF THE PERFORIN C2 DOMAIN WITH LIPID MEMBRANES
249, p3l4cB_, 0.5758, 3.45, 0.080, 154, 100, STRUCTURAL BASIS OF MEMBRANE-TARGETING BY DOCK180
250, d1cjyB1, 0.5755, 3.65, 0.069, 132, 101, HUMAN CYTOSOLIC PHOSPHOLIPASE A2
251, d1rlwA_, 0.5751, 3.65, 0.069, 132, 101, CALCIUM-PHOSPHOLIPID BINDING DOMAIN FROM CYTOSOLIC PHOSPHOLIPASE A2
252, p3w57A_, 0.5749, 3.63, 0.058, 171, 104, STRUCTURE OF A C2 DOMAIN
253, d2cjsA1, 0.5747, 3.45, 0.091, 123, 99, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
254, d3kwtA_, 0.5735, 3.45, 0.091, 123, 99, MUNC13-1 C2B-DOMAIN CALCIUM-FREE
255, p4y1tA_, 0.5734, 3.62, 0.081, 121, 99, STRUCTURAL BASIS FOR CA2+-MEDIATED INTERACTION OF THE PERFORIN C2 DOMAIN WITH LIPID MEMBRANES
256, p5ug6A_, 0.5730, 3.43, 0.051, 129, 98, PERFORIN C2 DOMAIN - T431D
257, d2nq3A1, 0.5730, 3.43, 0.051, 129, 98, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN ITCHY HOMOLOG E3 UBIQUITIN PROTEIN LIGASE
258, d2ep6A1, 0.5730, 3.57, 0.079, 129, 101, SOLUTION STRUCTURE OF THE SECOND C2 DOMAIN FROM HUMAN MCTP2 PROTEIN
259, d1d5rA1, 0.5730, 2.78, 0.119, 144, 84, CRYSTAL STRUCTURE OF THE PTEN TUMOR SUPPRESSOR
260, d1bciA_, 0.5730, 3.52, 0.059, 147, 101, C2 DOMAIN OF CYTOSOLIC PHOSPHOLIPASE A2 NMR MINIMIZED AVERAGE STRUCTURE
261, d2cjsB2, 0.5729, 3.72, 0.050, 210, 101, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
262, p5ug7A_, 0.5728, 3.72, 0.050, 210, 101, CALCIUM BOUND PERFORIN C2 DOMAIN - T431D
263, p3nsjA2, 0.5725, 3.55, 0.082, 118, 98, THE X-RAY CRYSTAL STRUCTURE OF LYMPHOCYTE PERFORIN
264, d2yrbA1, 0.5723, 2.87, 0.058, 171, 86, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN FROM HUMAN KIAA1005 PROTEIN
265, p4npkA1, 0.5719, 2.83, 0.058, 172, 86, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS CALCIUM BOUND
266, p4qj3B2, 0.5713, 2.90, 0.069, 171, 87, STRUCTURE OF A FRAGMENT OF HUMAN PHOSPHOLIPASE C-BETA3 DELTA472-559 IN COMPLEX WITH GALPHAQ
267, d2cjtC_, 0.5708, 3.19, 0.084, 122, 95, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
268, p5ue8A2, 0.5704, 3.87, 0.059, 179, 101, THE CRYSTAL STRUCTURE OF MUNC13-1 C1C2BMUN DOMAIN
269, p2ygmA1, 0.5702, 3.87, 0.059, 179, 101, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN
270, p3w57B_, 0.5701, 3.49, 0.051, 127, 98, STRUCTURE OF A C2 DOMAIN
271, d2isdA2, 0.5698, 3.50, 0.061, 126, 99, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT
272, p3v0hA2, 0.5696, 3.16, 0.053, 111, 94, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) COMPLEXED WITH D-MYO- INOSITOL-145-TRIPHOSPHATE
273, p2jqzA_, 0.5694, 3.16, 0.053, 111, 94, SOLUTION STRUCTURE OF THE C2 DOMAIN OF HUMAN SMURF2
274, d1djiA2, 0.5694, 3.68, 0.082, 150, 98, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM
275, p3m7fB_, 0.5693, 3.32, 0.104, 116, 96, CRYSTAL STRUCTURE OF THE NEDD4 C2/GRB10 SH2 COMPLEX
276, p3pycA_, 0.5692, 3.19, 0.084, 126, 95, CRYSTAL STRUCTURE OF HUMAN SMURF1 C2 DOMAIN
277, p4qj4B2, 0.5689, 3.20, 0.084, 123, 95, STRUCTURE OF A FRAGMENT OF HUMAN PHOSPHOLIPASE C-BETA3 DELTA472-569 BOUND TO IP3 AND IN COMPLEX WITH GALPHAQ
278, d3kwuA1, 0.5686, 3.81, 0.087, 131, 104, MUNC13-1 C2B-DOMAIN CALCIUM BOUND
279, d1djzA2, 0.5686, 3.81, 0.087, 131, 104, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-45-BISPHOSPHATE
280, d1isdA3, 0.5685, 3.41, 0.063, 126, 95,  
281, d1djxB2, 0.5685, 3.41, 0.063, 126, 95, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-145-TRISPHOSPHATE
282, d1djzB2, 0.5682, 3.79, 0.099, 133, 101, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-45-BISPHOSPHATE
283, p4iqhA_, 0.5680, 3.45, 0.061, 123, 98, CRYSTAL STRUCTURE ANALYSIS OF DYSFERLIN C2A VARIANT 1 (C2AV1)
284, p3v0jB2, 0.5679, 3.52, 0.093, 155, 97, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) DELETION OF 401-405
285, d1djxA2, 0.5679, 3.52, 0.093, 155, 97, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-145-TRISPHOSPHATE
286, d1qasB2, 0.5675, 3.21, 0.084, 126, 95, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1
287, d1djwA2, 0.5675, 3.19, 0.095, 167, 95, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-12-CYCLIC- MONOPHOSPHONATE
288, p4npjB2, 0.5674, 3.19, 0.095, 167, 95, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
289, p4iqhC_, 0.5674, 3.77, 0.058, 143, 104, CRYSTAL STRUCTURE ANALYSIS OF DYSFERLIN C2A VARIANT 1 (C2AV1)
290, d1djgB2, 0.5672, 3.77, 0.058, 143, 104, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH LANTHANUM
291, p4w8jA4, 0.5669, 3.58, 0.061, 127, 99, STRUCTURE OF THE FULL-LENGTH INSECTICIDAL PROTEIN CRY1AC REVEALS INTRIGUING DETAILS OF TOXIN PACKAGING INTO IN VIVO FORMED CRYSTALS
292, d2vnoB_, 0.5669, 3.87, 0.080, 180, 100, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP B-TRISACCHARIDE LIGAND.
293, p5iz5A1, 0.5668, 3.87, 0.080, 180, 100, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2
294, d2vngB_, 0.5667, 3.61, 0.083, 127, 96, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP A-TRISACCHARIDE LIGAND.
295, d3b7yA_, 0.5665, 3.36, 0.104, 107, 96, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE E3 UBIQUITIN- PROTEIN LIGASE NEDD4
296, d2cjtD_, 0.5660, 2.95, 0.069, 172, 87, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
297, d2vnrA_, 0.5658, 2.95, 0.069, 172, 87, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS.
298, p3v0eA2, 0.5656, 3.18, 0.053, 111, 94, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 256-576(C363S)
299, d2nsqA_, 0.5654, 3.51, 0.093, 131, 97, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE HUMAN E3 UBIQUITIN-PROTEIN LIGASE NEDD4-LIKE PROTEIN
300, p3v0dA2, 0.5652, 3.55, 0.061, 141, 98, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S)
301, p3v0fA2, 0.5651, 3.64, 0.140, 131, 100, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM II
302, p3v0hB2, 0.5646, 3.51, 0.093, 131, 97, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) COMPLEXED WITH D-MYO- INOSITOL-145-TRIPHOSPHATE
303, p4qj5B2, 0.5643, 3.76, 0.101, 135, 99, STRUCTURE OF A FRAGMENT OF HUMAN PHOSPHOLIPASE C-BETA3 DELTA472-581 BOUND TO IP3 AND IN COMPLEX WITH GALPHAQ
304, d2vnoA_, 0.5643, 3.71, 0.121, 132, 99, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP B-TRISACCHARIDE LIGAND.
305, d2vngA1, 0.5641, 3.71, 0.121, 132, 99, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP A-TRISACCHARIDE LIGAND.
306, p5iz5B1, 0.5639, 3.88, 0.090, 180, 100, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2
307, d1qatB2, 0.5636, 3.56, 0.101, 133, 99, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA COMPLEX WITH SAMARIUM (III) CHLORIDE
308, p3v0dB2, 0.5634, 3.56, 0.101, 133, 99, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S)
309, d2isdB2, 0.5633, 3.52, 0.093, 131, 97, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT
310, d1qatA2, 0.5632, 3.61, 0.092, 131, 98, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA COMPLEX WITH SAMARIUM (III) CHLORIDE
311, p4p42A2, 0.5630, 3.50, 0.093, 131, 97, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
312, d1djiB2, 0.5630, 3.52, 0.093, 131, 97, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM
313, p2dmhA_, 0.5628, 3.67, 0.110, 128, 100, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN OF HUMAN MYOFERLIN
314, d1djwB2, 0.5628, 3.61, 0.051, 141, 98, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-12-CYCLIC- MONOPHOSPHONATE
315, d1djhB2, 0.5627, 3.51, 0.093, 131, 97, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH BARIUM
316, d1djhA2, 0.5624, 3.50, 0.093, 126, 97, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH BARIUM
317, p4npjA2, 0.5623, 3.62, 0.092, 131, 98, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
318, p3v0gB1, 0.5622, 3.58, 0.051, 121, 98, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
319, p6ewiB_, 0.5620, 3.55, 0.120, 128, 100, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) A200P + G307S MUTANT 
320, p3l9bA_, 0.5617, 3.61, 0.092, 131, 98, CRYSTAL STRUCTURE OF RAT OTOFERLIN C2A
321, p5ue8B4, 0.5616, 2.76, 0.072, 130, 83, THE CRYSTAL STRUCTURE OF MUNC13-1 C1C2BMUN DOMAIN
322, p3v0gC2, 0.5616, 2.76, 0.072, 130, 83, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
323, p5izrC1, 0.5614, 2.97, 0.093, 173, 86, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
324, p3v0jA2, 0.5612, 3.74, 0.060, 139, 100, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) DELETION OF 401-405
325, p3v0gA2, 0.5612, 3.74, 0.060, 139, 100, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
326, p3v0fB2, 0.5611, 2.96, 0.093, 173, 86, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM II
327, p3v0iA2, 0.5609, 3.81, 0.101, 144, 99, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 256-576 E411F
328, d1djgA2, 0.5608, 3.69, 0.083, 127, 96, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH LANTHANUM
329, p3aweB2, 0.5607, 2.94, 0.093, 172, 86, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (248-576)
330, d3b7yB_, 0.5606, 3.62, 0.051, 140, 98, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE E3 UBIQUITIN- PROTEIN LIGASE NEDD4
331, p5x7rA9, 0.5605, 3.96, 0.061, 140, 99, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE COMPLEXED WITH ISOMALTOHEXAOSE
332, d1djyB2, 0.5604, 3.63, 0.061, 141, 98, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-245-TRISPHOSPHATE
333, d1djyA2, 0.5603, 3.63, 0.061, 141, 98, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-245-TRISPHOSPHATE
334, p3v0gD2, 0.5601, 3.62, 0.061, 140, 98, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
335, p3aweA2, 0.5600, 3.61, 0.061, 141, 98, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (248-576)
336, p3awgB2, 0.5598, 3.71, 0.072, 180, 97, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP G356A MUTANT (248-576)
337, p5x7qA4, 0.5597, 2.98, 0.093, 171, 86, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE COMPLEXED WITH MALTOHEXAOSE
338, p3awfB2, 0.5597, 2.98, 0.093, 171, 86, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (236-576)
339, p5x7sA9, 0.5594, 3.64, 0.061, 128, 99, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE TERBIUM DERIVATIVE
340, p5x7pA9, 0.5593, 3.62, 0.092, 131, 98, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE COMPLEXED WITH ACARBOSE
341, p5x7oA5, 0.5593, 3.65, 0.051, 141, 98, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE
342, p4itcA_, 0.5593, 3.36, 0.082, 131, 97, CRYSTAL STRUCTURE ANALYSIS OF THE K1 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
343, p3m1hD_, 0.5592, 3.62, 0.092, 131, 98, CRYSTAL STRUCTURE ANALYSIS OF THE K3 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
344, p3awgC2, 0.5590, 3.64, 0.051, 127, 98, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP G356A MUTANT (248-576)
345, p6ewhA_, 0.5589, 3.35, 0.082, 129, 97, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) G307S MUTANT 
346, p3qr1A2, 0.5589, 3.67, 0.101, 140, 99, CRYSTAL STRUCTURE OF L. PEALEI PLC21
347, p3m1hB_, 0.5589, 3.67, 0.101, 140, 99, CRYSTAL STRUCTURE ANALYSIS OF THE K3 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
348, p6ewgA_, 0.5587, 3.35, 0.082, 131, 97, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) 
349, p4xoiD_, 0.5587, 3.36, 0.082, 129, 97, STRUCTURE OF HSANILLIN BOUND WITH RHOA(Q63L) AT 2.1 ANGSTROMS RESOLUTION
350, p3qr1D3, 0.5584, 3.37, 0.082, 131, 97, CRYSTAL STRUCTURE OF L. PEALEI PLC21
351, p3wsoA2, 0.5578, 3.62, 0.051, 128, 98, CRYSTAL STRUCTURE OF THE SKP1-FBG3 COMPLEX
352, d3jxsA_, 0.5578, 3.62, 0.051, 128, 98, CRYSTAL STRUCTURE OF XG34 AN EVOLVED XYLOGLUCAN BINDING CBM
353, p3aweC2, 0.5578, 3.60, 0.051, 141, 98, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (248-576)
354, d1qasA2, 0.5575, 3.70, 0.119, 182, 101, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1
355, d2fjuB2, 0.5570, 3.57, 0.071, 126, 99, ACTIVATED RAC1 BOUND TO ITS EFFECTOR PHOSPHOLIPASE C BETA 2
356, d5b4nA_, 0.5566, 3.57, 0.071, 126, 99, STRUCTURE ANALYSIS OF FUNCTION ASSOCIATED LOOP MUTANT OF SUBSTRATE RECOGNITION DOMAIN OF FBS1 UBIQUITIN LIGASE
357, p6ewiA_, 0.5563, 3.56, 0.125, 106, 96, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) A200P + G307S MUTANT 
358, p3awfC2, 0.5561, 3.52, 0.062, 139, 97, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (236-576)
359, d5b4nB_, 0.5558, 3.53, 0.062, 122, 96, STRUCTURE ANALYSIS OF FUNCTION ASSOCIATED LOOP MUTANT OF SUBSTRATE RECOGNITION DOMAIN OF FBS1 UBIQUITIN LIGASE
360, p5izrA1, 0.5557, 3.62, 0.061, 141, 98, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
361, p5izrB1, 0.5556, 3.67, 0.061, 141, 99, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
362, p5ixcB1, 0.5555, 3.64, 0.052, 139, 97, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE
363, p4gwnA4, 0.5552, 3.67, 0.061, 140, 98, CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA
364, p3m1hC_, 0.5552, 3.37, 0.082, 131, 97, CRYSTAL STRUCTURE ANALYSIS OF THE K3 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
365, p3m1hA_, 0.5552, 3.37, 0.082, 131, 97, CRYSTAL STRUCTURE ANALYSIS OF THE K3 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
366, p5x7rB9, 0.5551, 3.58, 0.052, 138, 96, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE COMPLEXED WITH ISOMALTOHEXAOSE
367, p5x7oB6, 0.5547, 3.69, 0.101, 146, 99, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE
368, p5izrD1, 0.5547, 3.69, 0.101, 146, 99, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
369, p5x7qB9, 0.5546, 2.95, 0.143, 155, 84, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE COMPLEXED WITH MALTOHEXAOSE
370, p5x7sB9, 0.5545, 3.37, 0.082, 131, 97, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE TERBIUM DERIVATIVE
371, p3qr0A2, 0.5541, 3.37, 0.082, 131, 97, CRYSTAL STRUCTURE OF S. OFFICINALIS PLC21
372, p5x7pB9, 0.5540, 3.61, 0.061, 141, 98, CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-16- GLUCOSYLTRANSFERASE COMPLEXED WITH ACARBOSE
373, d2y64A1, 0.5539, 3.57, 0.062, 138, 96, XYLOPENTAOSE BINDING MUTATED (X-2 L110F) CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE
374, p5ixcA1, 0.5538, 3.60, 0.052, 138, 96, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE
375, p4iqhB_, 0.5538, 2.96, 0.143, 155, 84, CRYSTAL STRUCTURE ANALYSIS OF DYSFERLIN C2A VARIANT 1 (C2AV1)
376, p4gnkD5, 0.5532, 3.61, 0.052, 138, 96, CRYSTAL STRUCTURE OF GALPHAQ IN COMPLEX WITH FULL-LENGTH HUMAN PLCBETA3
377, p4gnkB2, 0.5530, 2.95, 0.143, 155, 84, CRYSTAL STRUCTURE OF GALPHAQ IN COMPLEX WITH FULL-LENGTH HUMAN PLCBETA3
378, d5dpnA1, 0.5520, 2.96, 0.143, 155, 84, ENGINEERED CBM X-2 L110F IN COMPLEX WITH BRANCHED CARBOHYDRATE XXXG.
379, p4gwmA4, 0.5518, 2.96, 0.143, 155, 84, CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA
380, d3jxsB_, 0.5517, 2.96, 0.143, 155, 84, CRYSTAL STRUCTURE OF XG34 AN EVOLVED XYLOGLUCAN BINDING CBM
381, d2y6jA1, 0.5515, 2.94, 0.059, 169, 85, X-2 ENGINEERED MUTATED CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE
382, d2y6hA1, 0.5514, 2.96, 0.094, 176, 85, X-2 L110F CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE
383, d2y6gA1, 0.5514, 2.96, 0.094, 176, 85, CELLOPENTAOSE BINDING MUTATED (X-2 L110F) CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE
384, d2y6kA_, 0.5512, 3.59, 0.062, 138, 96, XYLOTETRAOSE BOUND TO X-2 ENGINEERED MUTATED CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE
385, d4bj0A1, 0.5509, 3.84, 0.117, 181, 103, XYLOGLUCAN BINDING MODULE (CBM4-2 X2-L110F) IN COMPLEX WITH BRANCHED XYLOSES
386, d2y6lA1, 0.5505, 3.91, 0.080, 162, 100, XYLOPENTAOSE BINDING X-2 ENGINEERED MUTATED CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE
387, p2ygmB2, 0.5504, 3.91, 0.080, 162, 100, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN
388, p4p42B1, 0.5502, 2.83, 0.083, 175, 84, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
389, d2zkmX2, 0.5501, 3.78, 0.127, 181, 102, CRYSTAL STRUCTURE OF PHOSPHOLIPASE C BETA 2
390, p5dfzA1, 0.5495, 3.84, 0.069, 208, 102, STRUCTURE OF VPS34 COMPLEX II FROM S. CEREVISIAE.
391, p3awgA2, 0.5493, 3.92, 0.080, 161, 100, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP G356A MUTANT (248-576)
392, p2v5yA1, 0.5492, 3.13, 0.070, 181, 86, CRYSTAL STRUCTURE OF THE RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU ECTODOMAIN
393, p3awfA2, 0.5491, 2.59, 0.073, 166, 82, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (236-576)
394, p4gwmB3, 0.5481, 3.54, 0.062, 138, 96, CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA
395, p2ygmA2, 0.5479, 3.38, 0.082, 126, 97, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN
396, p2wxhA1, 0.5477, 3.71, 0.073, 122, 96, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW14.
397, d3jxsC_, 0.5474, 2.90, 0.071, 174, 84, CRYSTAL STRUCTURE OF XG34 AN EVOLVED XYLOGLUCAN BINDING CBM
398, p2wxmA1, 0.5473, 4.12, 0.066, 174, 106, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH DL06.
399, p3ohmB2, 0.5471, 3.56, 0.062, 138, 96, CRYSTAL STRUCTURE OF ACTIVATED G ALPHA Q BOUND TO ITS EFFECTOR PHOSPHOLIPASE C BETA 3
400, p2yglA2, 0.5465, 2.93, 0.071, 174, 84, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71
401, p2qzqA_, 0.5465, 3.59, 0.072, 124, 97, CRYSTAL STRUCTURE OF C-TERMINAL OF AIDA
402, d2c9aA2, 0.5464, 3.59, 0.072, 125, 97, CRYSTAL STRUCTURE OF THE MAM-IG MODULE OF RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU
403, p3km5A_, 0.5463, 3.55, 0.074, 124, 95, CRYSTAL STRUCTURE ANALYSIS OF THE K2 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP)
404, p2qz5B_, 0.5462, 2.95, 0.118, 167, 85, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF AIDA
405, p6ftnA1, 0.5461, 2.95, 0.118, 167, 85, MPI3KD IN COMPLEX WITH AZ2 
406, d2e33A_, 0.5459, 3.09, 0.082, 170, 85, STRUCTURAL BASIS FOR SELECTION OF GLYCOSYLATED SUBSTRATE BY SCFFBS1 UBIQUITIN LIGASE
407, p2wxpA1, 0.5456, 3.02, 0.083, 174, 84, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH GDC-0941.
408, d1k45A1, 0.5455, 2.98, 0.143, 155, 84, THE SOLUTION STRUCTURE OF THE CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE.
409, p2e31A1, 0.5453, 2.99, 0.143, 155, 84, STRUCTURAL BASIS FOR SELECTION OF GLYCOSYLATED SUBSTRATE BY SCFFBS1 UBIQUITIN LIGASE
410, p5ngbA1, 0.5452, 3.56, 0.052, 137, 96, X-RAY DIFFRACTION CRYSTAL STRUCTURE OF THE MURINE PI3K P110DELTA IN COMPLEX WITH A PAN INHIBITOR
411, d1pmjX_, 0.5449, 2.98, 0.143, 155, 84, CRYSTAL STRUCTURE OF CALDICELLULOSIRUPTOR SACCHAROLYTICUS CBM27-1
412, p6eyzA5, 0.5445, 3.00, 0.143, 155, 84, PI3 KINASE DELTA IN COMPLEX WITH 4-FLUOROPHENYL 5-(4-(5-((4- ISOPROPYLPIPERAZIN-1-YL)METHYL)OXAZOL-2-YL)-1H-INDAZOL-6-YL)-2- METHOXYNICOTINATE
413, p5t7fB1, 0.5443, 3.68, 0.062, 134, 97, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-643624
414, p2wxlA1, 0.5443, 2.99, 0.143, 147, 84, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH ZSTK474.
415, p2wxqA1, 0.5442, 2.90, 0.071, 166, 84, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH AS15.
416, p2e32C2, 0.5442, 2.90, 0.071, 166, 84, STRUCTURAL BASIS FOR SELECTION OF GLYCOSYLATED SUBSTRATE BY SCFFBS1 UBIQUITIN LIGASE
417, p6al6A_, 0.5441, 3.75, 0.062, 124, 97, CRYSTAL STRUCTURE HPIC1 IN P42 SPACE GROUP
418, p2yglB2, 0.5439, 3.54, 0.101, 127, 99, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71
419, p2wxgA1, 0.5439, 3.55, 0.103, 134, 97, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW13.
420, p5t2lA1, 0.5437, 3.56, 0.103, 143, 97, MPI3KD IN COMPLEX WITH 7L
421, p5vlrA2, 0.5436, 2.81, 0.083, 165, 84, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A TRIFLUORO-ETHYL- PYRAZOL-PYROLOTRIAZINE INHIBITOR
422, p5t8iA1, 0.5435, 3.24, 0.116, 158, 86, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-9901
423, p2wxkA1, 0.5434, 2.65, 0.073, 166, 82, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH INK666.
424, p2e32A2, 0.5434, 2.65, 0.073, 165, 82, STRUCTURAL BASIS FOR SELECTION OF GLYCOSYLATED SUBSTRATE BY SCFFBS1 UBIQUITIN LIGASE
425, p2e26A2, 0.5434, 2.64, 0.073, 165, 82, CRYSTAL STRUCTURE OF TWO REPEAT FRAGMENT OF REELIN
426, p6al6B_, 0.5433, 2.63, 0.073, 165, 82, CRYSTAL STRUCTURE HPIC1 IN P42 SPACE GROUP
427, p5l72A2, 0.5428, 2.64, 0.073, 165, 82, PI3 KINASE DELTA IN COMPLEX WITH N-[6-(5-METHANESULFONAMIDO-6- METHOXYPYRIDIN-3-YL)-13-DIHYDRO-2-BENZOFURAN-4-YL]-2-(MORPHOLIN-4- YL)ACETAMIDE
428, p3a7qA3, 0.5427, 2.79, 0.071, 165, 84, STRUCTURAL BASIS FOR SPECIFIC RECOGNITION OF REELIN BY ITS RECEPTORS
429, d1oh4A_, 0.5427, 2.65, 0.073, 166, 82, STRUCTURAL AND THERMODYNAMIC DISSECTION OF SPECIFIC MANNAN RECOGNITION BY A CARBOHYDRATE-BINDING MODULE
430, p5dxuA3, 0.5426, 3.28, 0.080, 180, 87, P110DELTA/P85ALPHA WITH GDC-0326
431, p2wxnA1, 0.5426, 3.63, 0.052, 108, 96, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH DL07.
432, p5azxA_, 0.5423, 3.50, 0.125, 122, 96, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 1)
433, p2wxiA1, 0.5421, 3.52, 0.062, 119, 97, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW30.
434, p6al8D_, 0.5419, 3.52, 0.062, 119, 97, CRYSTAL STRUCTURE HPIC1 Y101F/F138S
435, d1k42A1, 0.5417, 3.58, 0.063, 137, 95, THE SOLUTION STRUCTURE OF THE CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE.
436, p6fihA1, 0.5416, 2.86, 0.131, 162, 84, CRYSTAL STRUCTURE OF THE ANX2 ECTODOMAIN FROM ARABIDOPSIS THALIANA 
437, p4xohB1, 0.5416, 2.86, 0.131, 162, 84, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
438, p4xe0A1, 0.5416, 3.78, 0.062, 138, 97, IDELALISIB BOUND TO THE P110 SUBUNIT OF PI3K DELTA
439, p6al7B_, 0.5414, 3.05, 0.106, 155, 85, CRYSTAL STRUCTURE HPIC1 F138S
440, p5wppA_, 0.5413, 3.33, 0.092, 179, 87, CRYSTAL STRUCTURE HPIC1 W73M/K132M
441, p6al8B_, 0.5412, 3.87, 0.069, 371, 102, CRYSTAL STRUCTURE HPIC1 Y101F/F138S
442, p6al8A_, 0.5411, 2.87, 0.071, 166, 84, CRYSTAL STRUCTURE HPIC1 Y101F/F138S
443, p5t28A1, 0.5409, 3.88, 0.069, 371, 102, MPI3KD IN COMPLEX WITH 5K
444, p5azwA_, 0.5409, 3.59, 0.103, 142, 97, CRYSTAL STRUCTURE OF P24BETA1 GOLD DOMAIN
445, p4v0iB1, 0.5409, 3.28, 0.092, 180, 87, WATER NETWORK DETERMINES SELECTIVITY FOR A SERIES OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS OVER PI3K-DELTA
446, p2x38A1, 0.5409, 3.28, 0.092, 180, 87, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH IC87114.
447, p5wppB_, 0.5406, 3.67, 0.061, 149, 98, CRYSTAL STRUCTURE HPIC1 W73M/K132M
448, p5t7fA1, 0.5406, 2.85, 0.143, 161, 84, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-643624
449, p5wpuA_, 0.5405, 2.94, 0.107, 179, 84, CRYSTAL STRUCTURE HPIC1 Y101S
450, d5kaeA2, 0.5403, 2.94, 0.107, 179, 84, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH QUINOLINE- CONTAINING INHIBITOR 5G
451, p5i4uA5, 0.5403, 3.69, 0.030, 154, 99, THE CRYSTAL STRUCTURE OF PI3KDELTA WITH COMPOUND 34
452, p5wpsA_, 0.5402, 3.69, 0.030, 154, 99, CRYSTAL STRUCTURE HPIC1 Y101F
453, p6al7D_, 0.5399, 3.86, 0.069, 375, 102, CRYSTAL STRUCTURE HPIC1 F138S
454, p3km5B_, 0.5399, 3.25, 0.059, 175, 85, CRYSTAL STRUCTURE ANALYSIS OF THE K2 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP)
455, p5azwB_, 0.5398, 3.83, 0.069, 370, 101, CRYSTAL STRUCTURE OF P24BETA1 GOLD DOMAIN
456, p6al7A_, 0.5397, 3.17, 0.084, 164, 83, CRYSTAL STRUCTURE HPIC1 F138S
457, p5wprA_, 0.5396, 2.91, 0.060, 178, 83, CRYSTAL STRUCTURE HPIC1 IN C2 SPACE GROUP
458, p5lcwL_, 0.5391, 3.82, 0.069, 370, 101, CRYO-EM STRUCTURE OF THE ANAPHASE-PROMOTING COMPLEX/CYCLOSOME IN COMPLEX WITH THE MITOTIC CHECKPOINT COMPLEX (APC/C-MCC) AT 4.2 ANGSTROM RESOLUTION
459, d1of4A_, 0.5391, 3.15, 0.080, 185, 87, STRUCTURAL AND THERMODYNAMIC DISSECTION OF SPECIFIC MANNAN RECOGNITION BY A CARBOHYDRATE-BINDING MODULE TMCBM27
460, p2wxfA1, 0.5390, 3.15, 0.080, 185, 87, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH PIK-39.
461, d3ibeA2, 0.5389, 3.90, 0.069, 148, 102, CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR BOUND TO PI3 KINASE GAMMA
462, p5gu5A_, 0.5388, 3.86, 0.069, 367, 102, CRYSTAL STRUCTURE OF P24GAMMA2 GOLD DOMAIN DETERMINED BY SULFUR-SAD
463, p5t8fA3, 0.5384, 3.90, 0.069, 371, 102, P110DELTA/P85ALPHA WITH TASELISIB (GDC-0032)
464, p2qz5A_, 0.5382, 3.78, 0.079, 371, 101, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF AIDA
465, d1e7uA2, 0.5380, 2.92, 0.060, 178, 83, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
466, p5iz5B3, 0.5377, 3.08, 0.082, 194, 85, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2
467, d3przA2, 0.5376, 3.10, 0.094, 179, 85, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
468, p5g05L_, 0.5372, 3.80, 0.059, 376, 101, CRYO-EM STRUCTURE OF COMBINED APO PHOSPHORYLATED APC
469, p5l9uL_, 0.5370, 3.88, 0.069, 374, 102, MODEL OF HUMAN ANAPHASE-PROMOTING COMPLEX/CYCLOSOME (APC/C-CDH1) WITH A CROSS LINKED UBIQUITIN VARIANT-SUBSTRATE-UBE2C (UBCH10) COMPLEX REPRESENTING KEY FEATURES OF MULTIUBIQUITINATION
470, p5a31L_, 0.5370, 3.78, 0.059, 158, 101, STRUCTURE OF THE HUMAN APC-CDH1-HSL1-UBCH10 COMPLEX.
471, p4ui9L_, 0.5370, 3.87, 0.059, 361, 101, ATOMIC STRUCTURE OF THE HUMAN ANAPHASE-PROMOTING COMPLEX
472, d3qarA2, 0.5369, 4.00, 0.068, 377, 103, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 32
473, d3oawA2, 0.5369, 2.93, 0.060, 178, 83, 4-METHYLPTERIDINEONES AS ORALLY ACTIVE AND SELECTIVE PI3K/MTOR DUAL INHIBITORS
474, d4anvA2, 0.5368, 3.15, 0.129, 150, 85, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
475, p2xonL_, 0.5368, 3.09, 0.082, 197, 85, STRUCTURE OF TMCBM61 IN COMPLEX WITH BETA-14-GALACTOTRIOSE AT 1.4 A RESOLUTION
476, p5a59A6, 0.5363, 3.83, 0.069, 148, 101, THE STRUCTURE OF GH101 E796Q MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH T-ANTIGEN
477, d3s2aA2, 0.5362, 3.11, 0.143, 149, 84, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH A QUINOLINE INHIBITOR
478, p5a56A5, 0.5359, 3.10, 0.034, 174, 88, THE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH 1-O-METHYL-T-ANTIGEN
479, p4a5wAa, 0.5359, 3.77, 0.059, 383, 101, CRYSTAL STRUCTURE OF C5B6
480, d3qaqA2, 0.5359, 3.87, 0.069, 371, 102, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 2 1
481, p2wxjA1, 0.5358, 2.79, 0.038, 100, 79, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH INK654.
482, d1he8A2, 0.5356, 2.79, 0.038, 100, 79, RAS G12V - PI 3-KINASE GAMMA COMPLEX
483, p5a5aA5, 0.5355, 3.87, 0.059, 364, 101, THE STRUCTURE OF GH101 E796Q MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH PNP-T-ANTIGEN
484, p5a58A5, 0.5353, 3.10, 0.094, 197, 85, THE STRUCTURE OF GH101 D764N MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH SERINYL T-ANTIGEN
485, p5g04L_, 0.5350, 2.83, 0.074, 164, 81, STRUCTURE OF THE HUMAN APC-CDC20-HSL1 COMPLEX
486, p2wxoA1, 0.5350, 2.63, 0.075, 190, 80, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH AS5.
487, p2wxrA1, 0.5349, 3.97, 0.088, 141, 102, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA.
488, d5g55A2, 0.5348, 3.97, 0.069, 366, 102, 3-QUINOLINE CARBOXAMIDES INHIBITORS OF PI3K
489, p4xohA1, 0.5348, 3.10, 0.094, 200, 85, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
490, d4flhA2, 0.5348, 3.10, 0.082, 199, 85, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH AMG511
491, p2e26A4, 0.5348, 3.10, 0.094, 200, 85, CRYSTAL STRUCTURE OF TWO REPEAT FRAGMENT OF REELIN
492, p4xunA_, 0.5347, 3.12, 0.094, 197, 85, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
493, d4dk5A2, 0.5347, 3.86, 0.069, 370, 101, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL- TRIAZINE INHIBITOR
494, p5l9tL_, 0.5346, 2.74, 0.114, 94, 79, MODEL OF HUMAN ANAPHASE-PROMOTING COMPLEX/CYCLOSOME (APC/C-CDH1) WITH E2 UBE2S POISED FOR POLYUBIQUITINATION WHERE UBE2S APC2 AND APC11 ARE MODELED INTO LOW RESOLUTION DENSITY
495, p4xutB_, 0.5346, 2.74, 0.114, 94, 79, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN IN COMPLEX WITH 13:14 BETA-GLUCOTETRAOSE B FROM PAENIBACILLUS BARCINONENSIS XYN10C
496, d4fjyA2, 0.5344, 3.77, 0.060, 351, 100, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH QUINOLINE-INDOLINE INHIBITOR 24F
497, p5mvxA1, 0.5342, 3.77, 0.060, 351, 100, HUMAN DLL4 C2-EGF3
498, d4xupC_, 0.5342, 3.93, 0.069, 371, 102, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
499, p4xupB2, 0.5342, 3.11, 0.082, 198, 85, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
500, p4xupF1, 0.5341, 3.84, 0.059, 371, 101, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
501, p2e26A3, 0.5341, 3.11, 0.082, 199, 85, CRYSTAL STRUCTURE OF TWO REPEAT FRAGMENT OF REELIN
502, d4xuoA_, 0.5340, 3.88, 0.091, 141, 99, STRUCTURE OF THE CBM22-1 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
503, p2zxqA3, 0.5338, 3.94, 0.059, 141, 101, CRYSTAL STRUCTURE OF ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE FROM BIFIDOBACTERIUM LONGUM (ENGBF)
504, p4xupD2, 0.5337, 2.94, 0.071, 199, 84, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
505, d4urkA2, 0.5337, 3.11, 0.094, 198, 85, PI3KG IN COMPLEX WITH AZD6482
506, p4e0sA0, 0.5337, 3.00, 0.107, 173, 84, CRYSTAL STRUCTURE OF C5B-6
507, p5sxaA6, 0.5334, 2.56, 0.117, 93, 77, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 10
508, p4indQ3, 0.5334, 3.19, 0.105, 198, 86, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
509, p4indE3, 0.5334, 3.11, 0.082, 200, 85, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
510, p6dgtA1, 0.5333, 3.11, 0.082, 200, 85, SELECTIVE PI3K BETA INHIBITOR BOUND TO PI3K DELTA 
511, p4indC3, 0.5333, 3.19, 0.095, 160, 84, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
512, p5khrL_, 0.5332, 3.05, 0.034, 171, 87, MODEL OF HUMAN ANAPHASE-PROMOTING COMPLEX/CYCLOSOME COMPLEX (APC15 DELETION MUTANT) IN COMPLEX WITH THE E2 UBE2C/UBCH10 POISED FOR UBIQUITIN LIGATION TO SUBSTRATE (APC/C-CDC20-SUBSTRATE-UBE2C)
513, d4xupE_, 0.5332, 3.77, 0.070, 370, 100, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
514, p4indT3, 0.5332, 3.71, 0.103, 134, 97, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
515, p4xurB_, 0.5331, 2.69, 0.052, 98, 77, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C IN COMPLEX WITH XYLOTETRAOSE
516, p4indN3, 0.5331, 2.69, 0.052, 98, 77, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
517, d4xuoB_, 0.5330, 3.89, 0.090, 385, 100, STRUCTURE OF THE CBM22-1 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
518, p4indP3, 0.5330, 3.91, 0.020, 152, 100, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
519, p4indM3, 0.5330, 3.96, 0.091, 149, 99, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
520, p4indA3, 0.5330, 3.96, 0.091, 149, 99, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
521, p4indR3, 0.5329, 3.50, 0.011, 105, 89, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
522, p4indJ3, 0.5329, 3.50, 0.011, 105, 89, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
523, p5ubtA3, 0.5328, 4.15, 0.029, 139, 103, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1- YL)PHENYL)PYRROLO[21-F][124] TRIAZIN-4-AMINE DERIVIATINE
524, p5b4xA2, 0.5328, 3.07, 0.096, 160, 83, CRYSTAL STRUCTURE OF THE APOER2 ECTODOMAIN IN COMPLEX WITH THE REELIN R56 FRAGMENT
525, p4xutC_, 0.5327, 3.04, 0.096, 160, 83, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN IN COMPLEX WITH 13:14 BETA-GLUCOTETRAOSE B FROM PAENIBACILLUS BARCINONENSIS XYN10C
526, p4xuqA_, 0.5327, 3.04, 0.096, 160, 83, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C IN COMPLEX WITH XYLOTRIOSE
527, p4xupA1, 0.5327, 3.04, 0.096, 160, 83, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
528, p4indB3, 0.5327, 3.85, 0.081, 138, 99, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
529, p4indK3, 0.5326, 4.02, 0.020, 138, 101, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
530, d3apfA2, 0.5326, 3.98, 0.030, 141, 101, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5039699
531, p4indL3, 0.5325, 3.27, 0.046, 146, 87, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
532, d1pmhX_, 0.5325, 3.27, 0.046, 146, 87, CRYSTAL STRUCTURE OF CALDICELLULOSIRUPTOR SACCHAROLYTICUS CBM27-1 IN COMPLEX WITH MANNOHEXAOSE
533, d3ps6A2, 0.5324, 3.26, 0.069, 192, 87, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
534, p4xupB1, 0.5323, 3.82, 0.092, 140, 98, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
535, p4xunC_, 0.5322, 3.28, 0.080, 192, 87, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
536, p5sxjA5, 0.5321, 3.18, 0.087, 117, 80, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 29
537, p5b4xC2, 0.5321, 3.82, 0.092, 140, 98, CRYSTAL STRUCTURE OF THE APOER2 ECTODOMAIN IN COMPLEX WITH THE REELIN R56 FRAGMENT
538, p3a7qA4, 0.5321, 3.86, 0.069, 371, 101, STRUCTURAL BASIS FOR SPECIFIC RECOGNITION OF REELIN BY ITS RECEPTORS
539, d4wwpA2, 0.5319, 3.98, 0.020, 138, 99, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH PYRIDINYLQUINOLINE INHIBITOR N-{(1S)-1-[8-CHLORO-2-(2-METHYLPYRIDIN- 3-YL)QUINOLIN-3-YL]ETHYL}-9H-PURIN-6-AMINE
540, p4ajwB1, 0.5319, 3.28, 0.080, 192, 87, DISCOVERY AND OPTIMIZATION OF NEW BENZIMIDAZOLE- AND BENZOXAZOLE- PYRIMIDONE SELECTIVE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
541, p5azxC_, 0.5318, 3.28, 0.080, 192, 87, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 1)
542, d4ps7A2, 0.5318, 3.26, 0.107, 160, 84, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH N-[6-(PYRIDIN-3-YL)-13- BENZOTHIAZOL-2-YL]ACETAMIDE
543, p4xutA_, 0.5317, 3.97, 0.049, 370, 102, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN IN COMPLEX WITH 13:14 BETA-GLUCOTETRAOSE B FROM PAENIBACILLUS BARCINONENSIS XYN10C
544, p4indI3, 0.5317, 3.74, 0.070, 370, 100, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
545, p4xuqC_, 0.5316, 4.04, 0.030, 140, 101, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C IN COMPLEX WITH XYLOTRIOSE
546, d4fjzA2, 0.5316, 3.98, 0.099, 139, 101, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH PYRROLO-PYRIDINE INHIBITOR 63
547, p4xurA_, 0.5315, 3.79, 0.093, 139, 97, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C IN COMPLEX WITH XYLOTETRAOSE
548, d4wwoA2, 0.5315, 3.54, 0.103, 155, 87, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH PHENYLQUINOLINE INHIBITOR N-{(1S)-1-[8-CHLORO-2-(3-FLUOROPHENYL)QUINOLIN-3-YL]ETHYL}- 9H-PURIN-6-AMINE
549, p4indG3, 0.5315, 3.54, 0.103, 155, 87, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
550, d3eneA2, 0.5314, 2.90, 0.048, 161, 84, COMPLEX OF PI3K GAMMA WITH AN INHIBITOR
551, d4wwnA2, 0.5313, 3.85, 0.092, 140, 98, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH (S)-N-(1-(7- FLUORO-2-(PYRIDIN-2-YL)QUINOLIN-3-YL)ETHYL)-9H-PURIN-6-AMINE AMG319 INHIBITOR
552, d4ps8A2, 0.5313, 3.13, 0.095, 153, 84, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH N-[6-(56-DIMETHOXYPYRIDIN-3- YL)-13-BENZOTHIAZOL-2-YL]ACETAMIDE
553, d4f1sA2, 0.5313, 2.90, 0.048, 161, 84, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL- TRIAZINE-SULFONAMIDE INHIBITOR
554, d1e8wA2, 0.5312, 3.79, 0.092, 140, 98, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
555, p4cc1A1, 0.5310, 3.72, 0.041, 161, 98, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
556, d1ux7A_, 0.5310, 2.91, 0.047, 159, 85, CARBOHYDRATE-BINDING MODULE CBM36 IN COMPLEX WITH CALCIUM AND XYLOTRIOSE
557, p5mwfD_, 0.5309, 2.92, 0.048, 161, 84, HUMAN JAGGED2 C2-EGF2
558, d1w0nA_, 0.5309, 2.91, 0.047, 161, 85, STRUCTURE OF UNCOMPLEXED CARBOHYDRATE BINDING DOMAIN CBM36
559, p4xohC1, 0.5308, 2.91, 0.047, 161, 85, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
560, p4xupD1, 0.5306, 3.22, 0.083, 158, 84, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
561, d1e8xA2, 0.5306, 2.93, 0.047, 156, 85, STRUCTURAL INSIGHTS INTO PHOSHOINOSITIDE 3-KINASE ENZYMATIC MECHANISM AND SIGNALLING
562, d4xz4A2, 0.5305, 3.32, 0.092, 195, 87, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH AN INHIBITOR
563, p4acqD0, 0.5303, 3.32, 0.092, 195, 87, ALPHA-2 MACROGLOBULIN
564, d3qk0A2, 0.5302, 2.92, 0.048, 162, 84, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH BENZOTHIAZOLE 82
565, p4acqA0, 0.5301, 3.99, 0.030, 136, 100, ALPHA-2 MACROGLOBULIN
566, d3preA2, 0.5301, 3.05, 0.076, 127, 79, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
567, p4acqC0, 0.5300, 3.05, 0.076, 127, 79, ALPHA-2 MACROGLOBULIN
568, p4acqB0, 0.5299, 4.08, 0.010, 156, 101, ALPHA-2 MACROGLOBULIN
569, d3lj3A2, 0.5299, 3.02, 0.099, 113, 81, PI3-KINASE-GAMMA WITH A PYRROLOPYRIDINE-BENZOFURAN INHIBITOR
570, d1qmmA2, 0.5299, 3.04, 0.099, 113, 81,  
571, p5nczA1, 0.5298, 3.96, 0.030, 350, 101, MPI3KD IN COMPLEX WITH INH1
572, p4jqrA_, 0.5298, 3.02, 0.099, 113, 81, CRYSTAL STRUCTURE OF A DUF4465 FAMILY PROTEIN (BACCAC_02373) FROM BACTEROIDES CACCAE ATCC 43185 AT 2.05 A RESOLUTION
573, d4fulA2, 0.5298, 3.18, 0.095, 153, 84, PI3 KINASE GAMMA BOUND TO A PYRMIDINE INHIBITOR
574, p4cbzB_, 0.5298, 2.92, 0.047, 159, 85, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
575, d2v4lA2, 0.5298, 3.02, 0.099, 113, 81, COMPLEX OF HUMAN PHOSPHOINOSITIDE 3-KINASE CATALYTIC SUBUNIT GAMMA (P110 GAMMA) WITH PIK-284
576, d5t23A4, 0.5295, 2.92, 0.048, 161, 84, PI3KG IN COMPLEX WITH 5D
577, d5edsA2, 0.5295, 3.02, 0.099, 113, 81, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH BENZIMIDAZOLE INHIBITOR 5
578, p5a55A5, 0.5294, 2.92, 0.047, 156, 85, THE NATIVE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4
579, d3csfA2, 0.5293, 3.02, 0.099, 114, 81, CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR DW2
580, p3j31P3, 0.5292, 3.04, 0.099, 113, 81, LIFE IN THE EXTREMES: ATOMIC STRUCTURE OF SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS
581, d1e7vA2, 0.5292, 3.02, 0.099, 114, 81, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
582, p5y96A1, 0.5291, 3.02, 0.099, 114, 81, CRYSTAL STRUCTURE OF ANXUR1 EXTRACELLULAR DOMAIN FROM ARABIDOPSIS THALIANA
583, p2dcjB2, 0.5291, 3.02, 0.099, 113, 81, A TWO-DOMAIN STRUCTURE OF ALKALIPHILIC XYNJ FROM BACILLUS SP. 41M-1
584, d2chxA2, 0.5288, 3.07, 0.099, 113, 81, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90
585, d2a4zA2, 0.5288, 4.13, 0.049, 400, 103, CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS604850
586, p5ncyA1, 0.5287, 3.23, 0.083, 160, 84, MPI3KD IN COMPLEX WITH INH1
587, d4anxA2, 0.5286, 2.91, 0.048, 161, 84, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
588, d4anuA2, 0.5286, 2.92, 0.048, 161, 84, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
589, d4anwA2, 0.5285, 2.93, 0.047, 158, 85, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
590, p4cc0A1, 0.5284, 3.08, 0.099, 113, 81, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
591, d2a5uA2, 0.5284, 3.08, 0.099, 113, 81, CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS605240
592, p4xupA2, 0.5280, 3.83, 0.092, 138, 98, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
593, p2xonA_, 0.5280, 3.05, 0.099, 113, 81, STRUCTURE OF TMCBM61 IN COMPLEX WITH BETA-14-GALACTOTRIOSE AT 1.4 A RESOLUTION
594, d5g2nA4, 0.5279, 3.10, 0.058, 181, 86, X-RAY STRUCTURE OF PI3KINASE GAMMA IN COMPLEX WITH COPANLISIB
595, p5t2bA1, 0.5278, 3.71, 0.082, 138, 97, MPI3KD IN COMPLEX WITH 5E
596, d3apdA2, 0.5278, 2.93, 0.047, 160, 85, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5108134
597, p3prxAb, 0.5276, 2.92, 0.048, 161, 84, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
598, d1jhjA_, 0.5276, 4.01, 0.010, 151, 100, CRYSTAL STRUCTURE OF THE APC10/DOC1 SUBUNIT OF THE HUMAN ANAPHASE- PROMOTING COMPLEX
599, p5t27A5, 0.5275, 3.24, 0.083, 160, 84, MPI3KD IN COMPLEX WITH 5D
600, p2dduA2, 0.5275, 3.61, 0.103, 150, 87, CRYSTAL STRUCTURE OF THE THIRD REPEAT DOMAIN OF REELIN
601, p4xlwD1, 0.5274, 3.78, 0.092, 140, 98, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
602, p4cbzA1, 0.5274, 3.96, 0.020, 346, 101, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
603, d3tjpA2, 0.5274, 2.75, 0.064, 100, 78, CRYSTAL STRUCTURE OF PI3K GAMMA WITH N6-(34-DIMETHOXYPHENYL)-2- MORPHOLINO-[45 -BIPYRIMIDINE]-2 6-DIAMINE
604, p4cc0B_, 0.5273, 4.08, 0.030, 136, 101, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
605, p3prxCb, 0.5272, 2.93, 0.048, 161, 84, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
606, p3hhmA3, 0.5270, 3.05, 0.099, 113, 81, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA AND THE DRUG WORTMANNIN
607, p3afgB3, 0.5270, 2.92, 0.048, 161, 84, CRYSTAL STRUCTURE OF PRON-TK-SP FROM THERMOCOCCUS KODAKARAENSIS
608, p3afgA1, 0.5270, 3.97, 0.050, 136, 100, CRYSTAL STRUCTURE OF PRON-TK-SP FROM THERMOCOCCUS KODAKARAENSIS
609, p4o9yB0, 0.5269, 2.93, 0.048, 161, 84, 
610, p2xomA_, 0.5268, 3.98, 0.070, 139, 100, ATOMIC RESOLUTION STRUCTURE OF TMCBM61 IN COMPLEX WITH BETA- 14-GALACTOTRIOSE
611, p5i5kAb, 0.5267, 3.06, 0.099, 113, 81, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
612, p6gq7A3, 0.5266, 4.07, 0.040, 136, 101, PI3KG IN COMPLEX WITH INH 
613, p5dxtA2, 0.5264, 3.81, 0.041, 139, 98, P110ALPHA WITH GDC-0326
614, p4o9yDd, 0.5264, 4.05, 0.040, 136, 101, 
615, p5xghA4, 0.5263, 3.79, 0.092, 140, 98, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
616, d4fhkA2, 0.5262, 4.00, 0.040, 143, 100, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDAZINE 19E
617, d4fhjA2, 0.5262, 3.73, 0.062, 168, 96, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDINE 2
618, p4cc1B1, 0.5262, 2.98, 0.146, 119, 82, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
619, p4xuqB_, 0.5261, 3.80, 0.122, 168, 98, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C IN COMPLEX WITH XYLOTRIOSE
620, p4ovvA3, 0.5259, 2.91, 0.146, 120, 82, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH DIC4-PIP2
621, p5mwfA_, 0.5258, 2.91, 0.146, 120, 82, HUMAN JAGGED2 C2-EGF2
622, p5mw5A_, 0.5258, 4.03, 0.078, 167, 102, HUMAN JAGGED2 C2-EGF2
623, p4xupF2, 0.5258, 4.03, 0.078, 167, 102, STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
624, d1e90A2, 0.5258, 2.95, 0.047, 159, 85, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
625, d3mjwA2, 0.5257, 4.08, 0.040, 136, 101, PI3 KINASE GAMMA WITH A BENZOFURANONE INHIBITOR
626, p2enqA_, 0.5257, 3.98, 0.040, 136, 100, SOLUTION STRUCTURE OF THE C2 DOMAIN FROM HUMAN PI3-KINASE P110 SUBUNIT ALPHA
627, p5dxhA6, 0.5251, 3.14, 0.112, 113, 80, P110ALPHA/P85ALPHA WITH COMPOUND 5
628, p5b4xC3, 0.5251, 3.78, 0.093, 134, 97, CRYSTAL STRUCTURE OF THE APOER2 ECTODOMAIN IN COMPLEX WITH THE REELIN R56 FRAGMENT
629, p5a9iC1, 0.5250, 3.17, 0.112, 113, 80, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF PEPT2
630, p4o9yJd, 0.5248, 3.88, 0.030, 136, 99, 
631, d3zvvA2, 0.5248, 3.16, 0.112, 116, 80, FRAGMENT BOUND TO PI3KINASE GAMMA
632, p5sxkA5, 0.5246, 3.16, 0.112, 116, 80, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 18
633, p5a9iB1, 0.5245, 3.17, 0.112, 113, 80, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF PEPT2
634, p2dckA2, 0.5245, 3.96, 0.051, 133, 99, A TETRAGONAL-LATTICE STRUCTURE OF ALKALIPHILIC XYNJ FROM BACILLUS SP. 41M-1
635, p4o9yHd, 0.5244, 4.09, 0.040, 136, 101, 
636, d3ml9A2, 0.5244, 4.06, 0.039, 375, 102, DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN
637, p4xlwB1, 0.5243, 3.46, 0.115, 218, 87, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
638, d6ankB2, 0.5242, 3.46, 0.115, 218, 87, SYNAPTOTAGMIN-7 C2A- AND C2B-DOMAINS
639, p5i5kBb, 0.5242, 3.90, 0.051, 132, 99, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
640, p4l1bA5, 0.5242, 3.85, 0.052, 153, 97, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA
641, p4jpsA6, 0.5242, 3.81, 0.083, 137, 96, CO-CRYSTAL STRUCTURES OF THE LIPID KINASE PI3K ALPHA WITH PAN AND ISOFORM SELECTIVE INHIBITORS
642, p2dcjA2, 0.5242, 4.26, 0.039, 135, 103, A TWO-DOMAIN STRUCTURE OF ALKALIPHILIC XYNJ FROM BACILLUS SP. 41M-1
643, p5t2mA1, 0.5241, 3.77, 0.093, 138, 97, MPI3KD IN COMPLEX WITH 7M
644, p5ae8A2, 0.5241, 3.24, 0.081, 185, 86, CRYSTAL STRUCTURE OF MOUSE PI3 KINASE DELTA IN COMPLEX WITH GSK2269557
645, p4xurC_, 0.5241, 3.89, 0.061, 135, 98, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C IN COMPLEX WITH XYLOTETRAOSE
646, d4xx5A2, 0.5240, 3.06, 0.099, 113, 81, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH AN INHIBITOR
647, p4fadA3, 0.5239, 4.09, 0.030, 140, 101, DESIGN AND SYNTHESIS OF A NOVEL PYRROLIDINYL PYRIDO PYRIMIDINONE DERIVATIVE AS A POTENT INHIBITOR OF PI3KA AND MTOR
648, p4tuuA2, 0.5237, 2.75, 0.076, 160, 79, ISOLATED P110A SUBUNIT OF PI3KA PROVIDES A PLATFORM FOR STRUCTURE- BASED DRUG DESIGN
649, p4o9yC0, 0.5237, 2.98, 0.159, 120, 82, 
650, p5t2dA1, 0.5236, 4.11, 0.040, 136, 101, MPI3KD IN COMPLEX WITH 7J
651, p5sxiA6, 0.5236, 4.04, 0.030, 129, 99, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 13
652, p5fi4A5, 0.5236, 3.96, 0.020, 375, 101, DISCOVERY OF IMIDAZO[12-A]-PYRIDINE INHIBITORS OF PAN-PI3 KINASES THAT ARE EFFICACIOUS IN A MOUSE XENOGRAFT MODEL
653, p5a57A5, 0.5236, 4.09, 0.040, 136, 101, THE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH PUGT
654, d4hleA2, 0.5236, 4.10, 0.040, 136, 101, COMPOUND 21 (1-ALKYL-SUBSTITUTED 124-TRIAZOLES)
655, p4zopA4, 0.5235, 4.09, 0.040, 136, 101, CO-CRYSTAL STRUCTURE OF LIPID KINASE PI3K ALPHA WITH A SELECTIVE PHOSPHATIDYLINOSITOL-3 KINASE ALPHA INHIBITOR
656, p4o9yAd, 0.5235, 3.77, 0.062, 168, 97, 
657, d3l16A2, 0.5233, 3.99, 0.040, 135, 99, DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT SELECTIVE AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3- KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER
658, d2rj2A1, 0.5233, 3.15, 0.070, 172, 86, CRYSTAL STRUCTURE OF THE SUGAR RECOGNIZING SCF UBIQUITIN LIGASE AT 1.7 RESOLUTION
659, p5uk8A3, 0.5232, 3.15, 0.070, 172, 86, THE CO-STRUCTURE OF (R)-4-(6-(1-(CYCLOPROPYLSULFONYL)CYCLOPROPYL)-2- (1H-INDOL-4-YL)PYRIMIDIN-4-YL)-3-METHYLMORPHOLINE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
660, p5swpA5, 0.5232, 3.29, 0.047, 145, 86, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 6 AND 24
661, p5okmB2, 0.5232, 4.10, 0.040, 132, 101, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
662, d3apcA2, 0.5232, 4.06, 0.039, 368, 102, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5132799
663, p5ul1A4, 0.5231, 3.81, 0.094, 135, 96, THE CO-STRUCTURE OF 3-AMINO-6-(4-((1-(DIMETHYLAMINO)PROPAN-2-YL) SULFONYL)PHENYL)-N-PHENYLPYRAZINE-2-CARBOXAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
664, p5t2iA1, 0.5230, 3.15, 0.076, 118, 79, MPI3KD IN COMPLEX WITH 7K
665, p4ovuA3, 0.5230, 3.19, 0.107, 161, 84, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH NISH2 OF P85ALPHA
666, p4o9yI0, 0.5230, 3.19, 0.107, 161, 84, 
667, p5mwfE1, 0.5229, 4.06, 0.030, 141, 101, HUMAN JAGGED2 C2-EGF2
668, d6audA2, 0.5228, 2.90, 0.083, 177, 84, PI3K-GAMMA K802T IN COMPLEX WITH CPD 8 10-((1-(TERT-BUTYL)PIPERIDIN-4- YL)SULFINYL)-2-(1-ISOPROPYL-1H-124-TRIAZOL-5-YL)-56- DIHYDROBENZO[F]IMIDAZO[12-D][14]OXAZEPINE
669, p5a9hA1, 0.5228, 2.90, 0.083, 177, 84, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF PEPT2
670, p6c1sA3, 0.5227, 3.81, 0.051, 148, 99, PHOSPHOINOSITIDE 3-KINASE GAMMA BOUND TO AN PYRROLOPYRIDINONE INHIBITOR 
671, p4wafA4, 0.5227, 3.88, 0.052, 153, 97, CRYSTAL STRUCTURE OF A NOVEL TETRAHYDROPYRAZOLO[15-A]PYRAZINE IN AN ENGINEERED PI3K ALPHA
672, p3l54A3, 0.5227, 3.88, 0.051, 136, 98, STRUCTURE OF PI3K GAMMA WITH INHIBITOR
673, p5sxcA5, 0.5226, 3.88, 0.051, 168, 98, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 8
674, d1e8yA2, 0.5225, 3.16, 0.089, 116, 79, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
675, p5xgiA3, 0.5224, 4.10, 0.030, 153, 101, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
676, p5iz5A3, 0.5224, 2.87, 0.089, 103, 79, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2
677, p3hizA3, 0.5224, 2.87, 0.089, 103, 79, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA
678, d3dbsA2, 0.5224, 2.87, 0.089, 103, 79, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH GDC0941
679, d3l17A2, 0.5222, 3.65, 0.129, 137, 93, DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT SELECTIVE AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3- KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER
680, p4xlwH_, 0.5221, 3.17, 0.035, 145, 85, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
681, d3ml8A2, 0.5221, 3.23, 0.075, 116, 80, DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN
682, d1umhA1, 0.5221, 4.14, 0.030, 136, 101, STRUCTURAL BASIS OF SUGAR-RECOGNIZING UBIQUITIN LIGASE
683, p5sxdA6, 0.5220, 4.08, 0.040, 143, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 22
684, p5itdA4, 0.5219, 3.74, 0.105, 137, 95, CRYSTAL STRUCTURE OF PI3K ALPHA WITH PI3K DELTA INHIBITOR
685, p4l23A3, 0.5219, 4.13, 0.040, 157, 101, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND PI-103
686, p3zxkB2, 0.5219, 3.75, 0.084, 133, 95, ENGINEERING THE ACTIVE SITE OF A GH43 GLYCOSIDE HYDROLASE GENERATES A BIOTECHNOLOGICALLY SIGNIFICANT ENZYME THAT DISPLAYS BOTH ENDO-XYLANASE AND EXO-ARABINOFURANOSIDASE ACTIVITY
687, p4xunB_, 0.5217, 3.79, 0.094, 133, 96, STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C
688, p4o9yEd, 0.5212, 3.89, 0.051, 168, 98, 
689, p5sxbA5, 0.5210, 3.06, 0.048, 161, 84, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 23
690, p5sx9A6, 0.5209, 4.06, 0.030, 152, 101, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 14
691, p5oknB2, 0.5209, 3.86, 0.122, 177, 98, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
692, d5jhaA4, 0.5209, 3.86, 0.122, 177, 98, STRUCTURE OF PHOSPHOINOSITIDE 3-KINASE GAMMA (PI3K) BOUND TO THE POTENT INHIBITOR PIKIN2
693, p5swoA5, 0.5208, 3.66, 0.031, 159, 96, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 4 AND 19
694, d4j6iA2, 0.5207, 3.18, 0.035, 164, 85, DISCOVERY OF THIAZOLOBENZOXEPIN PI3-KINASE INHIBITORS THAT SPARE THE PI3-KINASE BETA ISOFORM
695, p5a9iA1, 0.5206, 4.08, 0.040, 134, 100, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF PEPT2
696, d6ankA2, 0.5205, 3.98, 0.071, 130, 99, SYNAPTOTAGMIN-7 C2A- AND C2B-DOMAINS
697, d3dpdA2, 0.5204, 4.10, 0.030, 158, 101, ACHIEVING MULTI-ISOFORM PI3K INHIBITION IN A SERIES OF SUBSTITUTED 34-DIHYDRO-2H-BENZO[14]OXAZINES
698, p5ukjA4, 0.5203, 4.08, 0.030, 153, 101, THE CO-STRUCTURE OF NN-DIMETHYL-4-[(6R)-6-METHYL-5-(1H-PYRROLO[23- B]PYRIDIN-4-YL)-4567-TETRAHYDROPYRAZOLO[15- A]PYRAZIN-3- YL]BENZENESULFONAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
699, p5sx8A5, 0.5203, 3.34, 0.149, 153, 87, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 12 AND 15
700, p5azxB_, 0.5203, 4.02, 0.154, 96, 91, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 1)
701, p4tv3A2, 0.5203, 3.78, 0.105, 137, 95, ISOLATED P110A SUBUNIT OF PI3KA PROVIDES A PLATFORM FOR STRUCTURE- BASED DRUG DESIGN
702, p3pvmAb, 0.5203, 4.02, 0.040, 135, 99, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
703, p5sw8A5, 0.5202, 4.00, 0.030, 153, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 7 AND 11
704, d5oq4A2, 0.5202, 4.03, 0.141, 96, 92, PQR309 - A POTENT BRAIN-PENETRANT ORALLY BIOAVAILABLE PAN-CLASS I PI3K/MTOR INHIBITOR AS CLINICAL CANDIDATE IN ONCOLOGY
705, d4ps3A2, 0.5202, 2.92, 0.159, 119, 82, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH 1-[6-(5-METHOXYPYRIDIN-3-YL)- 13-BENZOTHIAZOL-2-YL]-3-[2-(1-PROPYL-1H-IMIDAZOL-4-YL)ETHYL]UREA
706, p3zimA3, 0.5202, 3.80, 0.117, 117, 94, DISCOVERY OF A POTENT AND ISOFORM-SELECTIVE TARGETED COVALENT INHIBITOR OF THE LIPID KINASE PI3KALPHA
707, p3klsB8, 0.5202, 3.78, 0.104, 133, 96, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SSL7
708, d2yc4B_, 0.5202, 3.94, 0.040, 148, 99, INTRAFLAGELLAR TRANSPORT COMPLEX 25-27 FROM CHLAMYDOMONAS
709, p5t2gA1, 0.5201, 3.40, 0.091, 138, 88, MPI3KD IN COMPLEX WITH 7I
710, p5swtA5, 0.5201, 3.10, 0.076, 116, 79, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 17 AND 27
711, p3pvmCb, 0.5201, 4.16, 0.010, 157, 100, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
712, p3klsAa, 0.5201, 4.14, 0.020, 160, 101, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SSL7
713, p5i6uA1, 0.5199, 3.01, 0.171, 123, 82, THE CRYSTAL STRUCTURE OF PI3KDELTA WITH COMPOUND 32
714, d4kz0A2, 0.5199, 3.01, 0.171, 123, 82, STRUCTURE OF PI3K GAMMA WITH IMIDAZOPYRIDINE INHIBITORS
715, p3ecqB2, 0.5199, 3.92, 0.040, 368, 100, ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE FROM STREPTOCOCCUS PNEUMONIAE: SEMET STRUCTURE
716, p5oknE2, 0.5198, 3.77, 0.083, 155, 96, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
717, p5okmG2, 0.5197, 3.08, 0.048, 161, 84, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
718, p4fa6A3, 0.5197, 3.98, 0.030, 136, 99, DESIGN AND SYNTHESIS OF A NOVEL PYRROLIDINYL PYRIDO PYRIMIDINONE DERIVATIVE AS A POTENT INHIBITOR OF PI3KA AND MTOR
719, p5mwfB1, 0.5195, 3.96, 0.061, 136, 98, HUMAN JAGGED2 C2-EGF2
720, p5azyB_, 0.5195, 4.09, 0.030, 148, 100, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 2)
721, d2chzA2, 0.5194, 3.79, 0.106, 118, 94, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-93
722, p5mw7A_, 0.5193, 4.11, 0.050, 368, 101, HUMAN JAGGED2 C2-EGF3
723, p3km9B7, 0.5193, 4.02, 0.030, 151, 100, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH THE C-TERMINAL BETA-GRASP DOMAIN OF SSL7
724, p3km9A7, 0.5193, 4.15, 0.020, 160, 101, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH THE C-TERMINAL BETA-GRASP DOMAIN OF SSL7
725, p4bfrB1, 0.5192, 3.23, 0.082, 183, 85, DISCOVERY AND OPTIMIZATION OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
726, d3nzsA2, 0.5192, 3.95, 0.020, 138, 98, STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE
727, p3ecqA2, 0.5191, 4.10, 0.030, 160, 101, ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE FROM STREPTOCOCCUS PNEUMONIAE: SEMET STRUCTURE
728, p5khuL_, 0.5190, 3.80, 0.117, 118, 94, MODEL OF HUMAN ANAPHASE-PROMOTING COMPLEX/CYCLOSOME (APC15 DELETION MUTANT) IN COMPLEX WITH THE MITOTIC CHECKPOINT COMPLEX (APC/C-CDC20- MCC) BASED ON CRYO EM DATA AT 4.8 ANGSTROM RESOLUTION
729, p5okmC2, 0.5189, 4.10, 0.040, 135, 100, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
730, d4hvbA2, 0.5189, 3.41, 0.058, 181, 86, CATALYTIC UNIT OF PI3KG IN COMPLEX WITH PI3K/MTOR DUAL INHIBITOR PF- 04979064
731, p4a55A3, 0.5189, 4.01, 0.040, 160, 100, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH ISH2 OF P85ALPHA AND THE INHIBITOR PIK-108
732, d1umiA1, 0.5189, 4.01, 0.040, 153, 101, STRUCTURAL BASIS OF SUGAR-RECOGNIZING UBIQUITIN LIGASE
733, p5mwfC1, 0.5187, 4.02, 0.050, 130, 100, HUMAN JAGGED2 C2-EGF2
734, p5swgA5, 0.5186, 3.80, 0.095, 136, 95, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 5 AND 21
735, p4o9yG9, 0.5185, 4.07, 0.040, 160, 101, 
736, p5swrA5, 0.5183, 4.05, 0.030, 368, 101, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 20 AND 26
737, p5ubrA3, 0.5182, 4.09, 0.020, 154, 101, CRYSTAL STRUCTURE OF PI3K ALPHA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1- YL)PHENYL)PYRROLO[21-F][124] TRIAZIN-4-AMINE DERIVIATINE
738, p5sxeA5, 0.5182, 3.80, 0.106, 118, 94, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 19 AND 28
739, p5sxfA6, 0.5178, 3.69, 0.021, 160, 95, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 9
740, d3n5aA_, 0.5178, 4.09, 0.040, 135, 100, SYNAPTOTAGMIN-7 C2B-DOMAIN CALCIUM BOUND
741, p5okoA2, 0.5177, 4.07, 0.141, 98, 92, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 DOUBLE MUTANT F593D/L597D
742, p5mwfF_, 0.5176, 4.07, 0.141, 98, 92, HUMAN JAGGED2 C2-EGF2
743, p5oknD2, 0.5175, 3.68, 0.096, 131, 94, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
744, p4xl1B_, 0.5175, 4.15, 0.020, 160, 101, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF1)
745, p4o9yFd, 0.5175, 4.09, 0.030, 138, 99, 
746, p3zxlB2, 0.5173, 4.14, 0.039, 150, 102, ENGINEERING THE ACTIVE SITE OF A GH43 GLYCOSIDE HYDROLASE GENERATES A BIOTECHNOLOGICALLY SIGNIFICANT ENZYME THAT DISPLAYS BOTH ENDO-XYLANASE AND EXO-ARABINOFURANOSIDASE ACTIVITY
747, p3zxkA2, 0.5173, 4.12, 0.040, 135, 100, ENGINEERING THE ACTIVE SITE OF A GH43 GLYCOSIDE HYDROLASE GENERATES A BIOTECHNOLOGICALLY SIGNIFICANT ENZYME THAT DISPLAYS BOTH ENDO-XYLANASE AND EXO-ARABINOFURANOSIDASE ACTIVITY
748, d1w15A_, 0.5173, 4.14, 0.030, 158, 101, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE PRESENCE OF CALCIUM
749, d4gb9A2, 0.5172, 3.69, 0.033, 99, 92, POTENT AND HIGHLY SELECTIVE BENZIMIDAZOLE INHIBITORS OF PI3K-DELTA
750, d4ezkA2, 0.5172, 4.00, 0.020, 157, 100, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
751, p4xbmB1, 0.5171, 4.02, 0.030, 135, 99, X-RAY CRYSTAL STRUCTURE OF NOTCH LIGAND DELTA-LIKE 1
752, d2yc2A_, 0.5171, 4.10, 0.020, 135, 99, INTRAFLAGELLAR TRANSPORT COMPLEX 25-27 FROM CHLAMYDOMONAS
753, d4n8mA_, 0.5170, 3.85, 0.051, 159, 99, STRUCTURAL POLYMORPHISM IN THE N-TERMINAL OLIGOMERIZATION DOMAIN OF NPM1
754, p5okmE2, 0.5168, 4.06, 0.040, 131, 99, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
755, p3zxlA2, 0.5168, 3.42, 0.058, 181, 86, ENGINEERING THE ACTIVE SITE OF A GH43 GLYCOSIDE HYDROLASE GENERATES A BIOTECHNOLOGICALLY SIGNIFICANT ENZYME THAT DISPLAYS BOTH ENDO-XYLANASE AND EXO-ARABINOFURANOSIDASE ACTIVITY
756, d3tl5A2, 0.5164, 3.42, 0.058, 181, 86, DISCOVERY OF GDC-0980: A POTENT SELECTIVE AND ORALLY AVAILABLE CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K)/MAMMALIAN TARGET OF RAPAMYCIN (MTOR) KINASE INHIBITOR FOR THE TREATMENT OF CANCER
757, p5oknF2, 0.5163, 4.10, 0.030, 151, 101, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
758, d3l08A2, 0.5160, 4.13, 0.010, 161, 100, STRUCTURE OF PI3K GAMMA WITH A POTENT INHIBITOR: GSK2126458
759, p5okoB2, 0.5159, 4.13, 0.010, 161, 100, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 DOUBLE MUTANT F593D/L597D
760, d2yc2B_, 0.5158, 4.12, 0.040, 157, 101, INTRAFLAGELLAR TRANSPORT COMPLEX 25-27 FROM CHLAMYDOMONAS
761, p5lkiE7, 0.5157, 3.39, 0.035, 220, 85, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE
762, p5lkiD7, 0.5157, 3.13, 0.048, 161, 84, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE
763, p5lkiC7, 0.5157, 3.79, 0.117, 118, 94, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE
764, p5lkiB7, 0.5157, 4.07, 0.020, 153, 100, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE
765, p5lkiA7, 0.5157, 4.03, 0.040, 149, 100, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE
766, p5okmF2, 0.5156, 3.98, 0.071, 130, 99, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
767, p5okmA2, 0.5156, 4.02, 0.040, 130, 99, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
768, p5okmD2, 0.5155, 4.05, 0.040, 153, 101, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
769, d1nlqE_, 0.5153, 4.05, 0.030, 135, 99, THE CRYSTAL STRUCTURE OF DROSOPHILA NLP-CORE PROVIDES INSIGHT INTO PENTAMER FORMATION AND HISTONE BINDING
770, p4xlwF_, 0.5151, 4.06, 0.141, 96, 92, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
771, p5oknA2, 0.5148, 3.30, 0.092, 137, 87, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
772, p4yknA7, 0.5147, 3.94, 0.082, 131, 97, PI3K ALPHA LIPID KINASE WITH ACTIVE SITE INHIBITOR
773, p3x0tA_, 0.5147, 4.16, 0.020, 160, 101, CRYSTAL STRUCTURE OF PIRA
774, p5l73A_, 0.5144, 4.08, 0.040, 152, 101, MAM DOMAIN OF HUMAN NEUROPILIN-1
775, p4kzcA3, 0.5144, 2.99, 0.038, 99, 79, STRUCTURE OF PI3K GAMMA WITH IMIDAZOPYRIDINE INHIBITORS
776, d3l13A2, 0.5144, 4.19, 0.040, 148, 101, CRYSTAL STRUCTURES OF PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS
777, d2yoaB_, 0.5143, 3.18, 0.076, 116, 79, SYNAPTOTAGMIN-1 C2B DOMAIN WITH PHOSPHOSERINE
778, d1tjmA1, 0.5142, 4.08, 0.020, 147, 99, CRYSTALLOGRAPHIC IDENTIFICATION OF SR2+ COORDINATION SITE IN SYNAPTOTAGMIN I C2B DOMAIN
779, d1h6yB_, 0.5141, 4.05, 0.051, 134, 99, THE ROLE OF CONSERVED AMINO ACIDS IN THE CLEFT OF THE C-TERMINAL FAMILY 22 CARBOHYDRATE BINDING MODULE OF CLOSTRIDIUM THERMOCELLUM XYN10B IN LIGAND BINDING
780, p5b4xA3, 0.5140, 3.95, 0.031, 136, 98, CRYSTAL STRUCTURE OF THE APOER2 ECTODOMAIN IN COMPLEX WITH THE REELIN R56 FRAGMENT
781, d5ccjB_, 0.5137, 3.86, 0.052, 135, 97, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
782, d2r83B1, 0.5136, 3.14, 0.076, 116, 79, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
783, d2r83A1, 0.5135, 3.06, 0.086, 131, 81, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
784, p5xgjA5, 0.5134, 4.02, 0.030, 368, 101, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
785, d1nlqB_, 0.5133, 4.05, 0.040, 153, 101, THE CRYSTAL STRUCTURE OF DROSOPHILA NLP-CORE PROVIDES INSIGHT INTO PENTAMER FORMATION AND HISTONE BINDING
786, d1h6xA1, 0.5132, 3.18, 0.076, 115, 79, THE ROLE OF CONSERVED AMINO ACIDS IN THE CLEFT OF THE C-TERMINAL FAMILY 22 CARBOHYDRATE BINDING MODULE OF CLOSTRIDIUM THERMOCELLUM XYN10B IN LIGAND BINDING
787, d4ezjA2, 0.5129, 3.15, 0.076, 116, 79, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
788, d4ezlA2, 0.5128, 4.15, 0.049, 368, 102, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
789, p3sd5A3, 0.5127, 4.07, 0.040, 129, 99, CRYSTAL STRUCTURE OF PI3K GAMMA WITH 5-(24-DIMORPHOLINOPYRIMIDIN-6- YL)-4-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE
790, p5vfgA_, 0.5126, 3.34, 0.082, 189, 85, SYNAPTOTAGMIN 1 C2B DOMAIN; LEAD-BOUND (HIGH OCCUPANCY) 
791, p5uk5B1, 0.5126, 3.83, 0.071, 128, 98, COMPLEX OF NOTCH1(EGF8-12) BOUND TO JAGGED1(N-EGF3)
792, d2chwA2, 0.5126, 3.91, 0.071, 129, 98, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110 ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-39
793, d1uovA1, 0.5126, 3.79, 0.095, 133, 95, CALCIUM BINDING DOMAIN C2B
794, d1e8zA2, 0.5126, 3.72, 0.041, 175, 97, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
795, d5ccjA_, 0.5125, 2.80, 0.039, 98, 77, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
796, d3cu7Bd, 0.5125, 3.88, 0.031, 135, 97, HUMAN COMPLEMENT COMPONENT 5
797, d3cu7Ad, 0.5125, 3.80, 0.092, 168, 98, HUMAN COMPLEMENT COMPONENT 5
798, d1h6yA_, 0.5124, 3.17, 0.076, 116, 79, THE ROLE OF CONSERVED AMINO ACIDS IN THE CLEFT OF THE C-TERMINAL FAMILY 22 CARBOHYDRATE BINDING MODULE OF CLOSTRIDIUM THERMOCELLUM XYN10B IN LIGAND BINDING
799, d1uowA1, 0.5123, 3.16, 0.076, 116, 79, CALCIUM BINDING DOMAIN C2B
800, p5kc2C1, 0.5122, 4.23, 0.069, 401, 102, NEGATIVE STAIN STRUCTURE OF VPS15/VPS34 COMPLEX
801, p5dfzC1, 0.5122, 4.23, 0.069, 401, 102, STRUCTURE OF VPS34 COMPLEX II FROM S. CEREVISIAE.
802, p5cciE2, 0.5122, 4.08, 0.040, 138, 100, STRUCTURE OF THE MG2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
803, p4v11A_, 0.5122, 3.35, 0.082, 189, 85, STRUCTURE OF SYNAPTOTAGMIN-1 WITH SV2A PEPTIDE PHOSPHORYLATED AT THR84
804, d1tjxA1, 0.5122, 3.17, 0.108, 152, 83, CRYSTALLOGRAPHIC IDENTIFICATION OF CA2+ COORDINATION SITES IN SYNAPTOTAGMIN I C2B DOMAIN
805, p5dxhD3, 0.5120, 4.16, 0.069, 132, 102, P110ALPHA/P85ALPHA WITH COMPOUND 5
806, p3t8mA3, 0.5119, 3.72, 0.097, 130, 93, RATIONAL DESIGN OF PI3K-ALPHA INHIBITORS THAT EXHIBIT SELECTIVITY OVER THE PI3K-BETA ISOFORM
807, p3r7rA3, 0.5119, 4.05, 0.030, 150, 101, STRUCTURE-BASED DESIGN OF THIENOBENZOXEPIN INHIBITORS OF PI3-KINASE
808, p5ehdd_, 0.5118, 3.47, 0.058, 181, 86, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
809, p5hccA6, 0.5117, 3.70, 0.021, 162, 95, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND DERMACENTOR ANDERSONI RACI3.
810, d1xb9G1, 0.5117, 4.14, 0.049, 153, 102, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
811, p4indS3, 0.5115, 3.80, 0.118, 115, 93, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
812, d1w9tB_, 0.5115, 4.09, 0.040, 153, 101, STRUCTURE OF A BETA-13-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS IN COMPLEX WITH XYLOBIOSE
813, d1w9tA_, 0.5114, 3.86, 0.041, 136, 97, STRUCTURE OF A BETA-13-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS IN COMPLEX WITH XYLOBIOSE
814, d1w9sA_, 0.5114, 3.99, 0.040, 151, 100, STRUCTURE OF A BETA-13-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS
815, p5vffA_, 0.5113, 4.01, 0.040, 149, 100, SYNAPTOTAGMIN 1 C2B DOMAIN; LEAD-BOUND (LOW OCCUPANCY) 
816, p4indO3, 0.5113, 3.38, 0.091, 138, 88, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
817, p4indF3, 0.5113, 3.38, 0.091, 138, 88, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
818, d5ccjD1, 0.5112, 4.02, 0.070, 134, 100, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
819, p4xbmA1, 0.5112, 4.02, 0.070, 134, 100, X-RAY CRYSTAL STRUCTURE OF NOTCH LIGAND DELTA-LIKE 1
820, p4indH3, 0.5111, 3.86, 0.031, 156, 96, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
821, p4indD3, 0.5111, 3.93, 0.060, 129, 100, THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS
822, d1nlqA_, 0.5111, 3.90, 0.041, 158, 97, THE CRYSTAL STRUCTURE OF DROSOPHILA NLP-CORE PROVIDES INSIGHT INTO PENTAMER FORMATION AND HISTONE BINDING
823, p5hcdA5, 0.5110, 3.74, 0.120, 115, 92, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS MICROPLUS RACI2
824, p5hceA6, 0.5108, 3.17, 0.036, 221, 83, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS APPENDICULATUS RACI1
825, p5kj8F2, 0.5107, 3.17, 0.036, 220, 83, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
826, p5kj7F2, 0.5105, 3.60, 0.157, 132, 89, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
827, p2y3aA2, 0.5105, 3.60, 0.157, 132, 89, CRYSTAL STRUCTURE OF P110BETA IN COMPLEX WITH ICSH2 OF P85BETA AND THE DRUG GDC-0941
828, p5ccgF2, 0.5104, 3.88, 0.095, 135, 95, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
829, p5ixcB3, 0.5102, 3.92, 0.095, 135, 95, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE
830, p5ixcA3, 0.5101, 3.71, 0.032, 157, 95, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE
831, p5ccgE2, 0.5101, 3.07, 0.086, 132, 81, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
832, p4e9kA_, 0.5100, 3.07, 0.086, 132, 81, CRYSTAL STRUCTURE OF A DUF4465 FAMILY PROTEIN (BACOVA_04221) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.31 A RESOLUTION
833, d1w9sB_, 0.5100, 3.11, 0.063, 108, 79, STRUCTURE OF A BETA-13-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS
834, p4xl1E_, 0.5099, 3.11, 0.063, 108, 79, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF1)
835, p3r7qA3, 0.5098, 3.84, 0.072, 127, 97, STRUCTURE-BASED DESIGN OF THIENOBENZOXEPIN INHIBITORS OF PI3- KINASE
836, p5ehdb_, 0.5097, 3.17, 0.036, 221, 83, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
837, d5ccjC_, 0.5096, 3.17, 0.036, 221, 83, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
838, d5t0sA_, 0.5095, 4.14, 0.041, 137, 98, SYNAPTOTAGMIN 1 C2B DOMAIN CADMIUM-BOUND
839, p5ehda_, 0.5095, 3.84, 0.072, 127, 97, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
840, d1xe0B1, 0.5094, 3.91, 0.094, 136, 96, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
841, d1xb9I1, 0.5093, 4.00, 0.051, 128, 99, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
842, d3nzuA2, 0.5092, 3.03, 0.099, 132, 81, STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE
843, d2yoaA1, 0.5092, 3.72, 0.120, 112, 92, SYNAPTOTAGMIN-1 C2B DOMAIN WITH PHOSPHOSERINE
844, p2pn5A7, 0.5092, 3.72, 0.120, 112, 92, CRYSTAL STRUCTURE OF TEP1R
845, d1nlqC_, 0.5091, 3.72, 0.120, 112, 92, THE CRYSTAL STRUCTURE OF DROSOPHILA NLP-CORE PROVIDES INSIGHT INTO PENTAMER FORMATION AND HISTONE BINDING
846, p5ehdi_, 0.5090, 3.72, 0.120, 112, 92, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
847, p3zm8A1, 0.5090, 3.72, 0.120, 112, 92, CRYSTAL STRUCTURE OF PODOSPORA ANSERINA GH26-CBM35 BETA-(14)-MANNANASE
848, d1xe0I1, 0.5090, 3.72, 0.120, 112, 92, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
849, d5ehdG_, 0.5089, 4.04, 0.050, 129, 100, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
850, p5ccgK2, 0.5089, 3.89, 0.071, 129, 98, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
851, d1xe0F1, 0.5089, 4.04, 0.089, 130, 101, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
852, d5jhbA4, 0.5088, 3.15, 0.063, 98, 79, STRUCTURE OF PHOSPHOINOSITIDE 3-KINASE GAMMA (PI3K) BOUND TO THE POTENT INHIBITOR PIKIN3
853, p4l2yA4, 0.5088, 4.14, 0.060, 159, 100, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND COMPOUND 9D
854, d2yc4A_, 0.5087, 4.07, 0.080, 130, 100, INTRAFLAGELLAR TRANSPORT COMPLEX 25-27 FROM CHLAMYDOMONAS
855, p4g11A3, 0.5086, 3.96, 0.041, 144, 97, X-RAY STRUCTURE OF PI3K-GAMMA BOUND TO A 4-(MORPHOLIN-4-YL)- (6-OXO-1 6-DIHYDROPYRIMIDIN-2-YL)AMIDE INHIBITOR
856, p5kj8E2, 0.5085, 3.09, 0.122, 112, 82, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
857, p5kj7E2, 0.5084, 3.09, 0.122, 112, 82, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
858, p5okmH2, 0.5083, 3.53, 0.069, 174, 87, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
859, d5ehdH_, 0.5083, 3.53, 0.069, 174, 87, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
860, d1xb9E1, 0.5081, 3.78, 0.096, 126, 94, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
861, p5cchE2, 0.5080, 4.05, 0.030, 135, 99, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
862, d1w9wA_, 0.5080, 3.56, 0.101, 149, 89, STRUCTURE OF A BETA-13-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS IN COMPLEX WITH LAMINARIHEXAOSE
863, p3cstA3, 0.5078, 3.59, 0.101, 148, 89, CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR E5E2
864, d4n8mE_, 0.5076, 3.07, 0.082, 157, 85, STRUCTURAL POLYMORPHISM IN THE N-TERMINAL OLIGOMERIZATION DOMAIN OF NPM1
865, d2p1bI_, 0.5075, 3.25, 0.115, 153, 87, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
866, p5kj8K2, 0.5074, 3.25, 0.115, 153, 87, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
867, p5oknC2, 0.5073, 3.62, 0.101, 151, 89, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
868, d5w5dF_, 0.5072, 3.59, 0.101, 151, 89, CRYSTAL STRUCTURE OF THE PRIMED SNARE-COMPLEXIN-SYNAPTOTAGMIN-1 C2B COMPLEX
869, p5b4xC4, 0.5072, 3.59, 0.101, 151, 89, CRYSTAL STRUCTURE OF THE APOER2 ECTODOMAIN IN COMPLEX WITH THE REELIN R56 FRAGMENT
870, d2p1bE_, 0.5072, 3.76, 0.053, 144, 94, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
871, d2p1bG_, 0.5071, 3.24, 0.063, 97, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
872, p4lnvB8, 0.5070, 3.01, 0.082, 158, 85, CRYSTAL STRUCTURE OF TEP1S
873, p4y7mD2, 0.5069, 3.01, 0.082, 158, 85, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (835-1129) FROM EAEC
874, p4devF1, 0.5069, 4.07, 0.030, 135, 99, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
875, p4y7oB2, 0.5068, 3.76, 0.096, 135, 94, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (869-1107) FROM EAEC
876, d2p1bC_, 0.5068, 3.75, 0.098, 124, 92, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
877, d2p1bA_, 0.5068, 3.61, 0.101, 151, 89, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
878, p5oknH2, 0.5066, 3.91, 0.125, 167, 96, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
879, p3zxjB2, 0.5066, 4.05, 0.030, 135, 99, ENGINEERING THE ACTIVE SITE OF A GH43 GLYCOSIDE HYDROLASE GENERATES A BIOTECHNOLOGICALLY SIGNIFICANT ENZYME THAT DISPLAYS BOTH ENDO-XYLANASE AND EXO-ARABINOFURANOSIDASE ACTIVITY
880, p4devD1, 0.5065, 3.59, 0.101, 148, 89, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
881, d1bdyA_, 0.5063, 3.86, 0.096, 135, 94, C2 DOMAIN FROM PROTEIN KINASE C DELTA
882, p5l73B_, 0.5062, 3.60, 0.101, 148, 89, MAM DOMAIN OF HUMAN NEUROPILIN-1
883, p4devH1, 0.5061, 3.16, 0.077, 113, 78, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
884, p4devG1, 0.5061, 3.16, 0.077, 113, 78, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
885, d2p1bD_, 0.5061, 3.08, 0.082, 157, 85, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
886, p5kj7K2, 0.5060, 3.60, 0.101, 148, 89, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
887, p5b4xA4, 0.5059, 4.31, 0.050, 221, 101, CRYSTAL STRUCTURE OF THE APOER2 ECTODOMAIN IN COMPLEX WITH THE REELIN R56 FRAGMENT
888, p3u37H1, 0.5057, 4.31, 0.050, 221, 101, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
889, d5w5cF2, 0.5056, 4.31, 0.050, 221, 101, CRYSTAL STRUCTURE OF THE PRIMED SNARE-COMPLEXIN-SYNAPTOTAGMIN-1 C2AB COMPLEX
890, p3zxjA2, 0.5056, 3.68, 0.101, 152, 89, ENGINEERING THE ACTIVE SITE OF A GH43 GLYCOSIDE HYDROLASE GENERATES A BIOTECHNOLOGICALLY SIGNIFICANT ENZYME THAT DISPLAYS BOTH ENDO-XYLANASE AND EXO-ARABINOFURANOSIDASE ACTIVITY
891, d4n8mD_, 0.5054, 3.63, 0.124, 150, 89, STRUCTURAL POLYMORPHISM IN THE N-TERMINAL OLIGOMERIZATION DOMAIN OF NPM1
892, d2p1bJ_, 0.5053, 3.60, 0.101, 148, 89, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
893, d1xe0H1, 0.5053, 3.97, 0.061, 136, 98, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
894, p4devC1, 0.5052, 3.85, 0.097, 131, 93, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
895, p3a7qA2, 0.5052, 3.83, 0.097, 131, 93, STRUCTURAL BASIS FOR SPECIFIC RECOGNITION OF REELIN BY ITS RECEPTORS
896, d1xb9F1, 0.5052, 3.16, 0.051, 107, 79, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
897, p5okpA2, 0.5051, 3.17, 0.077, 113, 78, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 DOUBLE MUTANT F593D/L597D
898, d1xe0E1, 0.5051, 3.43, 0.087, 104, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
899, d5ehdE_, 0.5048, 3.22, 0.108, 114, 83, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
900, d1w16A_, 0.5048, 3.41, 0.059, 134, 85, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE ABSENCE OF CALCIUM
901, p4devE1, 0.5047, 3.41, 0.059, 134, 85, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
902, d2v4vA_, 0.5047, 3.47, 0.071, 134, 85, CRYSTAL STRUCTURE OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE FROM CLOSTRIDIUM CELLULOLYTICUM IN COMPLEX WITH XYLOSE
903, d1dyoB_, 0.5047, 3.47, 0.071, 134, 85, XYLAN-BINDING DOMAIN FROM CBM 22 FORMALLY X6B DOMAIN
904, p4nuyA2, 0.5046, 3.62, 0.101, 149, 89, CRYSTAL STRUCTURE OF ENDOS AN ENDO-BETA-N-ACETYL-GLUCOSAMINIDASE FROM STREPTOCOCCUS PYOGENES
905, p5waiF2, 0.5044, 3.23, 0.108, 113, 83, CRYSTAL STRUCTURE OF A SUZ12-RBBP4-JARID2-AEBP2 HETEROTETRAMERIC COMPLEX
906, p3u37E1, 0.5044, 3.23, 0.108, 114, 83, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
907, p2rd0A6, 0.5044, 3.61, 0.101, 151, 89, STRUCTURE OF A HUMAN P110ALPHA/P85ALPHA COMPLEX
908, d2p1bH_, 0.5043, 3.92, 0.082, 153, 97, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
909, p3u37D1, 0.5042, 3.23, 0.108, 113, 83, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
910, d2enjA1, 0.5042, 3.24, 0.108, 114, 83, SOLUTION STURCTURE OF THE C2 DOMAIN FROM HUMAN PROTEIN KINASE C THETA
911, p4nuzA2, 0.5041, 3.35, 0.075, 105, 80, CRYSTAL STRUCTURE OF A GLYCOSYNTHASE MUTANT (D233Q) OF ENDOS AN ENDO- BETA-N-ACETYL-GLUCOSAMINIDASE FROM STREPTOCOCCUS PYOGENES
912, p3zhnA_, 0.5041, 3.35, 0.075, 105, 80, CRYSTAL STRUCTURE OF THE T6SS LIPOPROTEIN TSSJ1 FROM PSEUDOMONAS AERUGINOSA
913, p3u37G1, 0.5041, 3.16, 0.077, 112, 78, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
914, p3u37C1, 0.5041, 3.16, 0.077, 112, 78, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
915, p3rx9A_, 0.5041, 3.72, 0.111, 147, 90, 3D STRUCTURE OF SCIN FROM AN ESCHERICHIA COLI PATOTYPE
916, p3u37A1, 0.5039, 3.49, 0.102, 147, 88, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
917, d5fbzC2, 0.5038, 4.18, 0.050, 148, 100, STRUCTURE OF SUBTILASE SUBHAL FROM BACILLUS HALMAPALUS - COMPLEX WITH CHYMOTRYPSIN INHIBITOR CI2A
918, p4devB1, 0.5036, 3.52, 0.102, 147, 88, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
919, p4devA1, 0.5036, 3.50, 0.012, 89, 85, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
920, p6en3A8, 0.5035, 3.51, 0.012, 89, 85, CRYSTAL STRUCTURE OF FULL LENGTH ENDOS FROM STREPTOCOCCUS PYOGENES IN COMPLEX WITH G2 OLIGOSACCHARIDE. 
921, d5ehdF_, 0.5035, 3.65, 0.101, 149, 89, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
922, p4lnvC8, 0.5035, 3.40, 0.058, 237, 86, CRYSTAL STRUCTURE OF TEP1S
923, p4lnvA7, 0.5035, 3.40, 0.058, 237, 86, CRYSTAL STRUCTURE OF TEP1S
924, d1xb9C1, 0.5035, 3.42, 0.059, 134, 85, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
925, d2p1bB_, 0.5034, 4.06, 0.052, 161, 96, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
926, p5lobC_, 0.5033, 4.06, 0.052, 161, 96, STRUCTURE OF THE CA2+-BOUND RABPHILIN3A C2B- SNAP25 COMPLEX (C2 SPACE GROUP)
927, d1bdyB_, 0.5033, 3.81, 0.097, 129, 93, C2 DOMAIN FROM PROTEIN KINASE C DELTA
928, p5ehdh_, 0.5032, 3.37, 0.050, 105, 80, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
929, p4bfrA1, 0.5032, 3.64, 0.101, 148, 89, DISCOVERY AND OPTIMIZATION OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
930, p4a1rB_, 0.5032, 3.70, 0.111, 151, 90, THE STRUCTURE OF SERRATIA MARCESCENS LIP A MEMBRANE BOUND COMPONENT OF THE TYPE VI SECRETION SYSTEM.
931, d1k5wA_, 0.5032, 3.07, 0.051, 106, 78, THREE-DIMENSIONAL STRUCTURE OF THE SYNAPTOTAGMIN 1 C2B- DOMAIN: SYNAPTOTAGMIN 1 AS A PHOSPHOLIPID BINDING MACHINE
932, p4a1rA_, 0.5029, 3.41, 0.087, 106, 80, THE STRUCTURE OF SERRATIA MARCESCENS LIP A MEMBRANE BOUND COMPONENT OF THE TYPE VI SECRETION SYSTEM.
933, p4a1rC_, 0.5028, 3.40, 0.087, 106, 80, THE STRUCTURE OF SERRATIA MARCESCENS LIP A MEMBRANE BOUND COMPONENT OF THE TYPE VI SECRETION SYSTEM.
934, p3u37F1, 0.5028, 4.15, 0.020, 133, 99, AN ACETYL XYLAN ESTERASE (EST2A) FROM THE RUMEN BACTERIUM BUTYRIVIBRIO PROTEOCLASTICUS.
935, d1xe0G1, 0.5028, 3.68, 0.111, 148, 90, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
936, d5ehdB_, 0.5027, 3.10, 0.128, 113, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
937, p4y7oC_, 0.5027, 3.10, 0.128, 113, 78, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (869-1107) FROM EAEC
938, p4y7oA2, 0.5025, 3.24, 0.064, 96, 78, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (869-1107) FROM EAEC
939, d1xe0A1, 0.5025, 3.34, 0.050, 107, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
940, p5ehdj_, 0.5024, 3.06, 0.095, 126, 84, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
941, d1yrkA1, 0.5024, 3.06, 0.095, 126, 84, THE C2 DOMAIN OF PKC<DELTA> IS A NEW PHOSPHO-TYROSINE BINDING DOMAIN
942, p5w4sA_, 0.5022, 3.36, 0.087, 104, 80, SOLUTION STRUCTURE OF C2 DOMAIN FROM PROTEIN KINASE C ALPHA IN TERNARY COMPLEX WITH CALCIUM AND V5-PHM PEPTIDE 
943, p5ehdc_, 0.5022, 3.34, 0.050, 106, 80, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
944, p5cciF2, 0.5021, 3.44, 0.103, 149, 87, STRUCTURE OF THE MG2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
945, p4bq4B1, 0.5021, 3.42, 0.087, 106, 80, STRUCTURAL ANALYSIS OF AN EXO-BETA-AGARASE
946, d1xb9A1, 0.5021, 4.09, 0.052, 128, 97, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
947, d3acgA_, 0.5020, 4.12, 0.031, 146, 98, CRYSTAL STRUCTURE OF CARBOHYDRATE-BINDING MODULE FAMILY 28 FROM CLOSTRIDIUM JOSUI CEL5A IN COMPLEX WITH CELLOBIOSE
948, d1xb9H1, 0.5020, 3.08, 0.089, 131, 79, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
949, d5fbzA2, 0.5019, 3.71, 0.088, 131, 91, STRUCTURE OF SUBTILASE SUBHAL FROM BACILLUS HALMAPALUS - COMPLEX WITH CHYMOTRYPSIN INHIBITOR CI2A
950, p4y7lB2, 0.5019, 3.56, 0.102, 149, 88, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (869-1107) FROM EAEC
951, p3p2bA3, 0.5019, 3.67, 0.101, 149, 89, CRYSTAL STRUCTURE OF PI3K GAMMA WITH 3-(2-MORPHOLINO-6-(PYRIDIN-3- YLAMINO)PYRIMIDIN-4-YL)PHENOL
952, d2cm6B_, 0.5018, 3.98, 0.080, 129, 100, CRYSTAL STRUCTURE OF THE C2B DOMAIN OF RABPHILIN3A
953, d3f00A1, 0.5015, 3.34, 0.050, 107, 80, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN I C2A DOMAIN WITH CU(II)
954, d1dyoA_, 0.5015, 3.44, 0.087, 105, 80, XYLAN-BINDING DOMAIN FROM CBM 22 FORMALLY X6B DOMAIN
955, d1xb9J1, 0.5014, 3.66, 0.101, 152, 89, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
956, d5ehdD_, 0.5012, 3.66, 0.101, 152, 89, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
957, p4a42B_, 0.5012, 3.44, 0.059, 134, 85, CPGH89CBM32-6 PRODUCED BY CLOSTRIDIUM PERFRINGENS
958, p4a42A_, 0.5011, 3.72, 0.098, 131, 92, CPGH89CBM32-6 PRODUCED BY CLOSTRIDIUM PERFRINGENS
959, d1of3B_, 0.5011, 3.21, 0.051, 106, 79, STRUCTURAL AND THERMODYNAMIC DISSECTION OF SPECIFIC MANNAN RECOGNITION BY A CARBOHYDRATE-BINDING MODULE TMCBM27
960, p5ehdg_, 0.5010, 3.07, 0.051, 100, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
961, p4bq5B1, 0.5010, 3.44, 0.103, 149, 87, STRUCTURAL ANALYSIS OF AN EXO-BETA-AGARASE
962, p4bq3A1, 0.5010, 4.14, 0.091, 126, 99, STRUCTURAL ANALYSIS OF AN EXO-BETA-AGARASE
963, d1xb9B1, 0.5010, 3.63, 0.101, 152, 89, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
964, p5lobB_, 0.5009, 3.61, 0.057, 150, 88, STRUCTURE OF THE CA2+-BOUND RABPHILIN3A C2B- SNAP25 COMPLEX (C2 SPACE GROUP)
965, d5ehdJ_, 0.5009, 3.23, 0.051, 100, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
966, p4y7mC2, 0.5009, 3.20, 0.051, 100, 79, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (835-1129) FROM EAEC
967, d1xe0J1, 0.5009, 3.00, 0.117, 103, 77, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
968, d5sv5A_, 0.5008, 3.44, 0.083, 108, 84, 1.0 ANGSTROM CRYSTAL STRUCTURE OF PRE-PEPTIDASE C-TERMINAL DOMAIN OF COLLAGENASE FROM BACILLUS ANTHRACIS.
969, d5lowA_, 0.5007, 3.36, 0.073, 129, 82, STRUCTURE OF THE CA2+-BOUND RABPHILIN 3A C2B DOMAIN SNAP25 COMPLEX (P21 SPACE GROUP)
970, d5ehdA_, 0.5007, 3.80, 0.081, 108, 86, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
971, d2p1bF_, 0.5007, 3.08, 0.051, 100, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
972, d5ehdC_, 0.5004, 3.06, 0.051, 100, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
973, d1xe0D1, 0.5003, 4.10, 0.079, 129, 101, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
974, p3x0tB_, 0.5002, 3.11, 0.037, 215, 81, CRYSTAL STRUCTURE OF PIRA
975, d1dqvA2, 0.5001, 3.36, 0.073, 129, 82, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN III C2A/C2B
